Exogenous lipid utilization by the gram-negative Vibrio cholerae by Pride, Aaron Charles
 
 
 
 
 
 
 
 
 
Copyright 
by 
Aaron Charles Pride 
2014 
 
 
  
The Dissertation Committee for Aaron Charles Pride Certifies that this is the 
approved version of the following dissertation: 
 
 
EXOGENOUS LIPID UTILIZATION BY THE GRAM-NEGATIVE 
VIBRIO CHOLERAE 
 
 
 
 
 
Committee: 
 
M. Stephen Trent, Supervisor 
Jeffrey Barrick 
David Hoffman 
Shelley Payne 
Marvin Whiteley 
EXOGENOUS LIPID UTILIZATION BY THE GRAM-NEGATIVE 
VIBRIO CHOLERAE 
 
 
by 
Aaron Charles Pride, B.S. 
 
 
 
Dissertation 
Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 
Doctor of Philosophy 
 
 
The University of Texas at Austin 
August 2014 
Dedication 
 
I dedicate this work to my wife, Morgan, for her unending support and love 
 
 
 v 
Acknowledgements 
 
My greatest thanks go to my mentor, Dr. M. Stephen Trent, for his continued 
commitment to helping me develop into a successful scientist. His encouragement and 
passion for research drove me to become better than I was and I would not be where I am 
now without his direction. I would also like to recognize my committee for their patience 
and advisement: Dr. Marvin Whiteley, Dr. Shelley Payne, Dr. David Hoffman, and Dr. 
Jeffrey Barrick. In addition, my fellow lab members, especially Dr. Carmen Herrera (who 
helped me through many experiments), have been integral in my success and I want to 
thank them for their support and companionship. 
Thanks to all my friends and family for sticking with me through the years. I offer 
special thanks to my father for his encouragement and for putting up with “one more year 
at most” for about four years. Most of all I want to thank my wife, Morgan. Without her 
constant love and care graduate school would have seemed insurmountable.  
 vi 
EXOGENOUS LIPID UTILIZATION BY THE GRAM-NEGATIVE 
VIBRIO CHOLERAE 
 
Aaron Charles Pride, Ph. D  
The University of Texas at Austin, 2014 
 
Supervisor:  M. Stephen Trent 
 
To overcome the membrane permeability barrier and low nutrient availability in 
the environment, Gram-negative organisms have evolved many mechanisms dedicated to 
the intake of nutrients.  One such mechanism is the long-chain fatty acid uptake pathway.  
This pathway involves machinery that transports fatty acids across the outer membrane 
and into the cell, where the lipid can be used for either nutrition or for remodeling the 
structure of the membrane.  Interestingly, the fatty acid species that can be recognized by 
this machinery differ between organisms; the aquatic pathogen Vibrio cholerae 
demonstrates a much wider substrate recognition profile than other Gram-negative 
species.  In this work we elaborate on the lipid nutrients accessible to V. cholerae, 
demonstrating that it can use lysophosphatidylcholine as both a carbon source as well as a 
source of fatty acids for remodeling its outer membrane.  We identify the enzyme 
responsible for the breakdown of lysophosphatidylcholine, VolA (Vibrio outer membrane 
lysophospholipase A). VolA is conserved in many Vibrio species as well as other aquatic 
Gram-negatives, annotated as a putative lipase.  We show VolA is co-expressed with the 
outer membrane fatty acid transporter FadL; FadL serves to transport across the outer 
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membrane those long-chain fatty acids freed from lysophosphatidylcholine by VolA.  
VolA is expressed on the surface of the cell as a membrane anchored lipoprotein; this is 
novel as VolA is the first identified example of a surface-localized lipoprotein 
phospholipase.  Biochemical characterization of VolA shows that it acts as a canonical 
lysophospholipase in vitro, suggesting that it works in tandem with the FadL transporter, 
freeing fatty acids from lysophosphatidylcholine at the surface of the cell to be brought in 
via the fatty acid uptake pathway.  This work expands on the currently understood lipid 
uptake abilities of Vibrio cholerae, demonstrating a novel mechanism for utilizing a 
nutrient not previously thought to metabolized.  VolA is an important to our 
understanding of the larger picture of lipid uptake and how it contributes to the survival 
of Gram-negative organisms.  
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Chapter 1: Introduction 
VIBRIO CHOLERAE, A GRAM-NEGATIVE HUMAN PATHOGEN 
 
The disease cholera has been a continued plague of humankind for centuries.  An 
acute infection of the small intestine, cholera manifests in patients as vomiting 
accompanied by intense, watery diarrhea.  Traditionally, this diarrhea is termed “rice-
water stool” due to its milky white appearance; victims of cholera lose fluid at a 
prodigious rate – nearly 500 mL per hour.  Left untreated, cholera will result in severe 
dehydration and even death within hours.  Cholera is a self-limiting disease, and 
treatments include supportive care in the form of fluid replenishment (1); antibiotic 
treatment can limit the length and severity of symptoms but is not considered a cure.  In 
1817, the first global pandemic of cholera originated in Southeast Asia, spreading 
through India infecting and killing hundreds of thousands of people.  Since this original 
pandemic there have been a total of seven pandemics, with the most recent pandemic 
beginning in 1961 and infecting between three and five million people every year (2).  In 
1854, the Italian physician Filippo Pacini observed a comma-shaped bacterium in the 
stools of cholera victims; this bacterium was later identified in 1883 by Robert Koch as 
Vibrio cholerae.   
Vibrio cholerae is a Gram-negative curved-rod bacillus. V. cholerae is normally 
found in marine, estuarine, and freshwater environments and has been associated with a 
variety of reservoirs including shellfish and copepods (3, 4).  Acquired via consumption 
of contaminated water reservoirs, V. cholerae colonizes the intestinal epithelium of the 
human host.  Colonization of the intestine and manifestation of disease is dependent on a 
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variety of virulence factors, including flagella, toxin co-regulated pilus, and cholera 
toxin, among others.   
When V. cholerae enters the intestinal lumen, it must travel through the thick 
mucous secretions to access the epithelium;  it does this via a single polar flagellum that 
drives motility through rotational motion(5).  The flagellum is a long, whip-like filament 
anchored to the cell via a flexible hook and a structure called the basal body.  Synthesis 
of the flagella is completed by the secretion of component proteins through the basal 
body, which self-assemble into the flagellar apparatus on the exterior of the cell.  
Chemotaxis in V. cholerae, which has been shown to be important in virulence(5), is 
dependent on expression of the flagellum.  Toxin co-regulated pilus (TCP) – a type-IV 
pilus – is involved in cell-to-cell association resulting in the formation of microcolonies, 
a key step in colonization of the epithelium (6, 7).  The tcp operon, expressing all the 
necessary components for assembly of the pilus is contained within a pathogenicity island 
inside the genome of V. cholerae.  Loss of expression of TCP results in severe 
colonization defects during infection (8, 9).  Once colonization is successful, the most 
important virulence factor – cholera toxin (CTx) – is expressed and stimulates rapid fluid 
entry into the lumen of the intestine (10).  CTx is vital to the pathogenesis of V. cholerae 
and is the cause of cholera disease symptoms (11).  Strains with a defect in CTx 
production do not produce the diarrhea common to toxin-producing strains.  The 
mechanism of the toxin’s action is well-characterized.  Initially, CTx binds to the host 
cell surface via specific contact with the monosialoganglioside GM1 (12).  Once bound, 
CTx is endocytosed.  In the cytoplasm, CTx acts as an ADP-ribosyltransferase, binding to 
the human Gs protein and catalyzing the transfer of an ADP-ribose to Gs.  This locks Gs 
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in a GTP-bound form, leading to uncontrolled activity of adenylyl cyclase and production 
of cAMP.  Increased concentrations of cAMP result in characteristic secretion of fluid 
from the intestinal epithelium, resulting in uncontrolled diarrhea and excretion of 
electrolytes (13).  
V. cholerae is an important human pathogen that causes disease world-wide.  
While a vaccine does exist, it is not used in the United States and has been shown to be 
only mildly effective.  V. cholerae has been reported as responsible for the deaths of over 
100,000 people per year, although estimates for unreported fatalities are much higher 
(14).  Cholera disease remains endemic in developing nations, especially where water 
sanitation efforts are lacking or absent.  A better understanding of the requirements for V. 
cholerae survival in both the environment and the human host will continue to give us a 
larger picture of the cholera model and more information on potential therapies. 
THE GRAM-NEGATIVE CELL ENVELOPE 
Gram-negative bacteria are unique in that they possess a cellular envelope made 
up of two membranes and a periplasmic space (Fig. 1.1) (15).  The inner membrane is 
composed of a phospholipid bilayer; in Gram-negatives the major phospholipid species 
that make up this membrane are phosphatidylethanolamine, phosphatidylglycerol, and 
cardiolipin (Fig. 1.2).  These phospholipids display variable acyl chain length and degree 
of unsaturation, with the predominant lipids having C16 or C18 acyl chains with 0 or 1 
unsaturation.  Most Gram-negative bacteria, including V. cholerae, are unable to 
synthesize phospholipids with acyl chains longer than 18 carbons.   
 4 
Figure 1.1 The Gram-negative cell envelope 
The cell envelope is composed of two lipid bilayers separated by a periplasmic space.  
The inner membrane is composed of phospholipids, while the outer membrane is an 
asymmetric bilayer made up of phospholipids and lipopolysaccharide.  The 
lipopolysaccharide present on the surface of the cell acts as a permeability barrier.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Major phospholipid species in the Gram-negative membrane 
Phospholipids contain fatty acids, glycerol, a phosphate group, and a variable polar head 
group.  The major phospholipids in the cell envelope are phosphatidylethanolamine (PE), 
phosphatidylglycerol (PG), and cardiolipin (CL). 
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The outer membrane is a complex asymmetric bilayer composed of an inner leaflet of 
phospholipids and an outer leaflet of the glycolipid lipopolysaccharide (LPS) (Fig. 1.1) 
(16).  LPS is comprised of three distinct domains: a lipid anchor called lipid A, a core 
domain made of sugars, and a long chain of repeating oligosaccharides called the O-
antigen.  LPS serves as the major antigenic determinant of the bacterium; V. cholerae 
strains are typed into serogroups based on the sugars that decorate LPS on the surface of 
the cell.  Despite the existence of a variety of V. cholerae serogroups, only two have been 
associated with the global pandemics of cholera disease.  V. cholerae O1 and O139 are 
the serogroups associated with cholera epidemics (2, 17, 18).  V. cholerae O1 can be 
further divided into the classical and El Tor biotypes.  The El Tor strain has been the 
topic of considerable study due to its involvement in the current pandemic of cholera.     
The outer membrane serves as a layer of protection, acting as a strong 
permeability barrier, preventing the entry of harmful chemicals and antimicrobial agents.  
In general the tightly packed nature of the membrane, along with the hydrophilic nature 
of the O-antigen does not permit molecules that are hydrophobic or larger in size (19).  
This barrier poses an interesting problem to the cell; while the protective effects of the 
outer membrane confer a survival advantage, the low permeability also precludes entry of 
important nutrients that cannot freely diffuse into the cell.  In addition, Gram-negative 
bacteria experience a variety of ecological niches during their life cycle, each with a 
diverse range of nutrient availability both in the types of nutrients present and their 
concentrations. To compensate for these challenges, Gram-negative organisms express 
many nutrient transport systems to facilitate passage through the outer membrane. 
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NUTRIENT TRANSPORT ACROSS THE GRAM-NEGATIVE MEMBRANE 
Transporters in general can be classified based on their mode of transport (Fig 
1.3).  Many nutrients are brought into the cell via the use of porins, water-filled pore-like 
proteins that passively transport their substrates (20–22).  In general porins are used only  
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Transport of nutrients in Gram-negative organisms 
The three major types of transporters are porins, TonB-dependent transporters, and 
facilitated diffusers. Porins are water-filled β-barrel proteins that allow diffusion down a 
concentration gradient but do not bind their substrates and generally exist as trimers. 
TonB-dependent transporters utilize TonB and its accessory proteins to transduce energy 
from the PMF of the cytoplasmic membrane and permit transport of nutrients against a 
concentration gradient. Facilitated transport involves the direct binding of substrates to 
complete transport. 
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for relatively small substrates (those less than ~600 daltons), and only function when 
driven by a concentration gradient.  Among the most well-known examples of proteins 
are the Omp transporters OmpF and OmpC, which are regulated by environmental 
osmolarity and responsible for the transport of low-molecular weight hydrophilic solutes 
(23, 24).   Structural characterization of porins have illuminated how they function in the 
outer membrane (25, 26).  Taking on an extremely stable β-barrel conformation, porins 
exist in the membrane as a homo-trimer.  The interior of the β-barrel is lined with 
positively- and negatively-charged side chains and filled with water, resulting in a strong 
polar character with the central pore.  The increased polar nature of the central channel 
precludes the entry of hydrophobic molecules.  To date porin homologs have been 
identified in many Gram-negative organisms, transporting a variety of substrates 
including sugars, ions, and amino acids.    
In addition to porins there are active transporters dependent on the cytoplasmic 
membrane-associated energy transducer TonB (27).  The outer membrane is devoid of 
energetic potential; additionally the periplasmic space has no available energy in the form 
of ATP due to the strongly oxidizing environment.  Thus transporters must rely on 
alternative sources of energy.  Here, nutrients are taken into the cell through substrate-
specific transporters driven by proton motive force of the cytoplasmic membrane via 
TonB (28).  TonB is a periplasm-spanning cytoplasmic membrane-anchored protein.  It 
interfaces with a cytoplasmic membrane complex made up of the ExbB and ExbD 
proteins.  The complex harvests energetic potential generated by proton-motive force, 
causing a conformational change in TonB.  This energized conformation is transduced 
through TonB to specific transporters in the outer membrane, allowing them to bring in 
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substrates against existing concentration gradients (29).   In V. cholerae and other Gram-
negatives, this system is commonly used for import of metal ions (30, 31), but has also 
been implicated in the transport of vitamin B12 and some carbohydrates.  
The last form of transport in Gram-negative organisms involves the use of 
facilitated diffusers.  Similar to porins, these proteins do not have an energy requirement.  
Instead, they trap their substrates in low-affinity binding sites and induce a 
conformational change, allowing the substrate to be transported into the cell.  This can 
occur even when the substrate concentration is very low.  Examples of these transport 
systems include the nucleoside transporter Tsx (32) and the fatty acid transporter FadL 
(33), which will be discussed later in this work.   
Most of the transporters identified thus far are suited for the transport of 
hydrophilic compounds; evolutionarily, this makes sense, as most of the nutrients 
required by the cell are hydrophilic.  This presents a problem for the transport of 
hydrophobic compounds, however, as passage of such substrates is energetically 
unfavorable.  Because of this, dedicated hydrophobic transporters are present in the outer 
membrane.   
FATTY ACID METABOLISM IN GRAM-NEGATIVES 
    Many nutrients important to proper cellular function are hydrophobic in nature.  
Systems involved in the transport of hydrophobic amino acids (34) and aromatic 
hydrocarbons (35–37) have been previously identified.  One of the most well-
characterized hydrophobic transporter is the pathway for uptake of long-chain fatty acids 
(LCFAs, >C12) (Fig. 1.4) (38).  Fatty acids play many important roles in the bacterial  
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Figure 1.4 Transport of long-chain fatty acids 
Long-chain fatty acids are initially transported into the cell via the outer membrane β-
barrel FadL.  They are then passaged through an unknown process through the inner 
membrane to the acyl CoA-ligase FadD.  The now-activated fatty acid can then be 
degraded in the β-oxidation cycle or handed off to the Pls enzymes of the phospholipid 
biosynthesis pathway. 
 
 
 
? 
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cell, including membrane synthesis and modification of proteins; they are also 
energetically costly to synthesize de novo.  The ability to increase cellular pools of fatty 
acids via transport of exogenous LCFAs thus can confer many advantages to the bacteria 
cell.  The first step of this pathway involves the use of an outer membrane β-barrel called 
FadL (33), which binds the fatty acid at the cell surface and deposits it into the inner 
leaflet of the outer membrane.  This process is well-characterized, with multiple studies 
describing the molecular mechanism of entry (39, 40).  FadL uses a low affinity binding 
site at the interface between a surface-exposed flexible loop and the extracellular 
environment to trap local LCFAs.  After binding the low affinity site, a conformational 
change occurs to bring the fatty acid into a high affinity binding site within the core of 
the protein.  A gap in the hydrogen bonding network of the β-barrel structure facilitates 
exit of the fatty acid into the space between the leaflets of the outer membrane.   
The next step of the process is less well-understood.  Via an unknown 
mechanism, the LCFA passes through the periplasmic space and the inner membrane.  It 
is unclear whether this process occurs via a periplasmic shuttle, similar to the transport of 
the lipid A anchor of LPS (41), or by simple diffusion.  The fatty acid passes through the 
inner membrane, drawn by the fatty acyl CoA ligase FadD (42).  This enzyme links the 
LCFA to a molecule of co-enzyme A in a two-step process.  Initially, FadD hydrolyzes 
ATP to generate a fatty acid-AMP molecule, which is immediately consumed along with 
CoASH to form acyl-CoA.  It appears that FadL can also be used to transport medium 
chain fatty acids (C8-C12) but not short chain fatty acids (>C8).  
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When grown in carbon-depleted conditions, fatty acids are shunted into the β-
oxidation pathway to facilitate ATP production and cell survival (43) (Fig 1.5).  The β-
oxidation cycle is a process that effectively couples degradation of fatty acids with the 
energy generation of the TCA cycle.  Two-carbon units are repeatedly removed from the 
fatty acid in the form of acetyl-CoA.  In Gram-negatives, the enzymes that perform this 
activity are encoded by the fad (fatty acid degradation) operon.  Immediately after 
activation by FadD, the acyl-CoA molecule is converted to 2-trans-enoyl-CoA via the 
acyl-CoA dehydrogenase FadE (44).  This step also causes the reduction of FAD+ to 
FADH2.  The next step is catalyzed by the multi-enzyme FadAB complex (45); FadB acts 
as an enoyl-CoA hydratase, generating L-3-hydroxyacyl-CoA, and immediately converts 
this intermediate with its L-3-hydroxacyl-CoA dehydrogenase activity, generating 3-
ketoacyl-CoA.  This step reduces a molecule of NAD+ to NADH.  The final step of the 
cycle is converted by the FadA subunit, which encodes the 3-ketoacyl-CoA thiolase.  
This step consumes a molecule of CoASH, removing acetyl-CoA and regenerating a two-
carbon-shortened acyl-CoA.  This process is more complicated for poly-unsaturated fatty 
acids.  Cis-trans-enoyl-CoA isomerase activity, which is also performed by FadB, 
converts unsaturations in the fatty acid to trans bonds, which can then be reduced by the 
2,4-dienoyl-CoA reductase FadH (46).  As the acetyl-CoA generated from each cycle can 
directly enter the TCA pathway, along with the regenerated FADH2 and NADH, each 
fatty acid can be metabolized to generate massive quantities of ATP.  The theoretical 
yield from a single palmitate (C16) is ~106 ATP, which is clearly beneficial to overall 
cell survival. 
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Figure 1.5 Gram-negative β-oxidation cycle 
Β-oxidation of exogenous LCFAs begins with the conversion of LCFA to acyl-CoA via 
the fatty acyl-CoA ligase FadD.  The dehydration of acyl-CoA to 2-trans-enoyl-CoA is 
performed by the dehydrogenase FadE.  The FadAB oxidation complex performs the 
remaining steps, hydrating the enoyl-CoA to L-3-hydroxyacyl-CoA and then dehydrating 
that into 3-ketoacyl-CoA.  A final thiolase step breaks down the intermediate to a 
molecule of acetyl-CoA, which is shunted into the TCA cycle, and acyl-CoA, which can 
be further broken down via repeated β-oxidation cycles. 
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The fad genes that encode the enzymes involved in fatty acid metabolism are all 
controlled by the same master regulator, FadR (47, 48).  Expression of the fad regulon is 
tightly controlled in the absence of LCFAs.  In its native state, FadR acts as a repressor of 
the entire β-oxidation pathway by binding to the fad operon, downregulating transcription 
from those promoters (49).  FadR also downregulates the expression of the fatty acid 
transport genes fadL and fadD.  To ensure that the cell has the proper intracellular 
concentration of fatty acids to synthesize the phospholipids required for building the cell 
envelope, FadR also acts as an activator of the fatty acid synthesis genes fabA and fabB 
(50).  When the cell does successfully take up LCFAs and convert them to acyl-CoA, 
FadR binds these activated lipids and undergoes a conformational change, rendering it no 
longer able to associate with DNA (51).  This is an efficient regulatory mechanism, 
allowing the cell to optimize expression of fatty acid degradation enzymes in the 
presence of exogenous fatty acids.  In turn, fatty acid synthesis genes are downregulated 
in the presence of LCFAs.  
When other carbon sources are available to the cell, activated LCFAs are shifted 
away from the β-oxidation machinery and into the general phospholipid biosynthesis 
pathway.  Phospholipid construction is performed by a conserved set of enzymatic steps, 
beginning with the generation of the common precursor phosphatidic acid and ending 
with phospholipid species-specific modification proteins (52, 53).  The first step of 
phospholipid biosynthesis in Gram-negatives is the conversion of glycerol-3-phosphate to 
phosphatidic acid via the acyltransferases PlsB/C – in Gram-positive organisms this step 
requires additional precursor synthesis by PlsX/Y (Fig. 1.6).  The acyl chains used by the 
PlsB/C enzymes are normally generated via the fatty acid biosynthesis pathway in the 
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form of acyl-ACP; in the presence of exogenous LCFAs, however, acyl-CoA generated 
by FadD can serve as the lipid donor.  This has two effects on the survival of the 
bacterium: the first is the reduced energetic load on the cell and the second is the ability 
to modify the structure of the cell envelope.  De novo synthesis of fatty acids via the Fab 
machinery is very costly; generation of a single palmitate requires 7 ATPs and 14 
NADPHs.  Recycling of phospholipids into their precursors can help reduce these costs 
(54); in the case of exogenous LCFAs, direct utilization by the PlsB/C machinery can 
also decrease the need for de novo synthesis.   
A more important consequence of using exogenous LCFAs in the phospholipid 
synthesis pathway is the larger effect on the architecture of the cell envelope. In the case 
of Gram-negative pathogens like V. cholerae, membrane integrity is an important 
property for the survival of the cell.  The ability of the cell to remodel the membrane is 
vital to this process.  When V. cholerae colonizes the human intestine, it is immersed in 
host lipids.  Bile, a complex compound secreted into the intestinal lumen to aid in 
digestion, contains multiple species of fatty acid including LCFAs (55, 56).  V. cholerae 
must travel through bile in order to reach the intestinal epithelium.  Detergent stress on 
the cell can occur due to significant differences between the lipid profiles of bile and the 
V. cholerae membrane.  Incorporation of LCFAs into the phospholipids of V. cholerae 
can allow the membranes to mimic the lipids of the intestine, decreasing overall stress via 
homeoviscous adaptation (57, 58).   
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Figure 1.6 Phospholipid precursor synthesis in bacteria 
Synthesis of phosphatidic acid, the precursor molecule used to build the phospholipids 
observed in the bacterial membrane.  The acyltransferase PlsB is normally found in 
Gram-negative organisms, while the PlsX/Y system is found in Gram-positive species. 
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LIPID UPTAKE IN V. CHOLERAE 
V. cholerae is unique in the context of its fatty acid transport system.  While most 
Gram-negative organisms have a single homolog of the outer membrane transporter FadL 
and the CoA ligase FadD, V. cholerae contains three homologs of each.  It is unclear why 
V. cholerae has multiple homologs of the LCFA uptake machinery.  The other enzymes 
of the fatty acid degradation pathway are not duplicated.  Based on previous data on 
LCFA uptake (57), it is possible that the additional homologs of FadL and FadD permit 
V. cholerae to transport a wider array of LCFAs, but this has yet to be proven.  V. 
cholerae is distinctive in terms of its LCFA substrate recognition profile.  E. coli 
recognizes some LCFA substrates, bringing in fatty acids with shorter acyl chains and a 
limited number of unsaturations.  V. cholerae, however, is capable of recognizing very-
long chain fatty acids (≥20 carbons) with a greater number of unsaturations (Table 1.1).  
This expanded ability to take up LCFAs is biologically important for V. cholerae, as it 
encounters a variety of fatty acids throughout its life cycle.  During growth in the aquatic 
environment V. cholerae will commonly associate with both marine organisms (59) as 
well as sediment (60, 61). Both of these niches are rich with polyunsaturated long-chain 
fatty acids (62, 63).  V. cholerae also encounters LCFAs during infection of the host.  In 
addition to the fatty acids naturally found in bile, the intestinal lumen is rich in LCFAs 
derived from dietary lipids (64).    
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Table 1.1 LCFA uptake profiles of E. coli and V. cholerae  
# Carbons** E. coli V. cholerae 
C18 18:0, 18:1, 18:2 18:0, 18:1, 18:2, 
18:3 C20 20:4 20:4, 20:5 
C22 - 22:5, 22:6 
C24 - 24:5 
Branched? No Yes 
* (57, 65) 
**LCFA defined by common convention, number of carbons : number of unsaturations 
 
Fatty acids are not the sole lipid that V. cholerae encounters during aquatic 
growth or in the human host.  In addition to fatty acids, V. cholerae is also exposed 
during its life cycle to sphingolipids (66), branch-chain lipids (67), phospholipids and 
phospholipid derivatives (68), among others.  Due to the larger substrate recognition 
profile of its LCFA uptake machinery and the energetic benefits of being able to 
metabolize other lipids found in the environment, it is possible that V. cholerae has other 
uncharacterized systems for the uptake of exogenous lipids. 
In this work we illuminate one such system that works in tandem with the existing 
fatty acid uptake machinery.  V. cholerae was tested for the ability to metabolize other 
commonly encountered lipids and was capable of utilizing lysophosphatidylcholine 
(LPC) as a carbon source.  We identify the protein responsible for this activity, VolA 
(Vibrio outer membrane lysophospholipase A).  Additionally, we show that VolA is a 
surface-exposed lipoprotein lysophospholipase.  This is novel, as there are no previously 
identified enzymes with similar character.  VolA is well-conserved in many Vibrio 
species and other aquatic Gram-negatives.  All identified homologs of VolA are 
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coexpressed with a homolog of the fatty acid transporter FadL; we believe that VolA 
functions to release a fatty acid from LPC to be brought into the cell through the fatty 
acid uptake pathway.  
Here, we highlight a previously uncharacterized lipid utilization mechanism in the 
Gram-negative V. cholerae.  We show how other lipids encountered in the course of the 
V. cholerae life cycle can be used as nutrients and as way to remodel the outer 
membrane. Our work serves to illuminate how other hydrophobic nutrients in the 
environment might be accessible to V. cholerae via currently unknown mechanisms. 
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Chapter 2: The Outer Surface Lipoprotein VolA Mediates Utilization of 
Exogenous Lipids by Vibrio cholerae1 
2.1 INTRODUCTION 
Gram-negative bacteria have developed several mechanisms for scavenging 
nutrients and other important metabolites from their surroundings.  One such mechanism, 
the fatty acid uptake pathway, allows Gram-negatives to import long-chain fatty acids 
(LCFAs) through their cell wall via the outer membrane transporter FadL and ligate them 
to coenzyme A using the fatty acyl coenzyme A ligase FadD.  After this ligation event, 
the activated fatty acids are destined for energy production or membrane construction.  
Exogenous fatty acids can serve as an energy source through the degradative β-oxidation 
pathway, which yields numerous activated carrier molecules for metabolic gain.  
Alternatively, the steep energy requirements for fatty acid biosynthesis can be 
circumvented by shunting the imported fatty acid into the membrane for phospholipid 
assembly (69). 
Previous research by our laboratory has shown that the Gram-negative human 
pathogen Vibrio cholerae is capable of utilizing diverse fatty acids from the surrounding 
environment, including very-long-chain fatty acids with multiple unsaturations (57).  This 
is in contrast to other Gram-negative organisms; Escherichia coli cannot metabolize fatty 
acids that are longer than 20 carbons nor process those fatty acids with equally high 
degrees of unsaturation (70–72).  This difference in substrate profiles between V. 
cholerae and other Gram-negatives may be attributed to V. cholerae’s multiple homologs 
of FadL and FadD.  A previous study from our laboratory determined that the bile 
secreted in the small intestine caused variation in the phospholipid profile 
                                                
1 Large portions of this chapter have been previously published (Pride A.C., Herrera C.M., Guan Z., Giles 
D.K., and Trent M.S. (2013) mBio 4:305-13.) 
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of V. cholerae when analyzed via thin-layer chromatography and mass spectrometry (57).  
All of the major phospholipids — including phosphatidylglycerol, 
phosphatidylethanolamine, and cardiolipin (Fig. 1.2) — showed an altered acylation 
profile.  Further experimentation revealed that the fatty acid component of bile 
specifically caused the altered migratory pattern.  The ability of V. cholerae to remodel 
its membrane phospholipids using exogenous lipid sources is an important advantage.  
This is further emphasized by the fact that environmental fatty acids found in aquatic 
sediment were also found to cause migratory shifts (57).  Altering the phospholipid 
profile in this manner can have dramatic effects on fitness via homeoviscous adaptation 
and reduced energetic requirements for membrane biogenesis. 
In their respective niches, Gram-negatives are in contact with diverse lipid 
chemical species, more than fatty acids alone, which can serve as potential carbon 
sources.  V. cholerae is immersed in lipids when colonizing the human intestine and 
when living in an aquatic environment (73).  For example, copepods, which constitute a 
common animal reservoir for V. cholerae, are known to synthesize phospholipids with 
very-long-chain fatty acyl tails, including phosphatidylcholine with attached 
docosapentaenoic (C22:5) and docosahexaenoic (C22:6) acids (74).  The lumen of the 
human intestine has significant amounts of lysophosphatidylcholine (LPC), derived from 
lecithinase activity on biliary and dietary sources of phosphatidylcholine (68, 75).  Given 
that V. cholerae has been shown to remodel its membrane architecture using exogenous 
lipids and that the bacteria have consistent exposure to these alternative 
lipids, V. cholerae might have evolved mechanisms to utilize these alternate sources of 
acyl chains for membrane remodeling as well. 
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Currently, while some steps in the transport of fatty acids into the bacterial cell 
are well characterized—such as those performed by FadL and FadD—other steps—such 
as how V. cholerae might utilize alternative lipid sources in conjunction with the fatty 
acid transport pathway—are enigmatic.  This work reports the ability of V. cholerae El 
Tor O1 to utilize LPC for nutrition and for remodeling of cell wall phospholipids.  We 
have identified a putative surface-exposed lipoprotein, VolA, that is responsible for this 
activity, and we suggest a mechanism for its function.  VolA mediates the unusual lipid 
utilization characteristics of V. cholerae and represents a newly discovered member of 
undercharacterized surface-exposed lipoprotein enzymes of Gram-negative bacteria. 
 
2.2 RESULTS 
2.2.1 Vibrio cholerae can use lysophosphatidylcholine as the sole carbon source 
In order to determine if V. cholerae El Tor O1 could utilize lysophospholipids, 
bacteria (strains are listed in Table 5.2) were grown in defined minimal medium with 
either 0.2% glucose, 2 mM stearoyl (C18:0)-lysophosphatidylcholine (LPC), or 2 mM 
stearic acid, serving as the sole carbon source (Fig. 2.1).  When E. coli and V. cholerae 
were grown with LCFAs, no difference in growth could be detected.  However, only 
V. cholerae was able to utilize LPC.  The maximal optical density at 600 nm (OD600) 
of V. cholerae grown on LPC was approximately half that of the LCFA-grown cultures 
(Fig. 2.1B); the slower growth on LPC is likely due to the rate-limiting step of release of   
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Figure 2.1 Growth of E. coli and V. cholerae on LPC or LCFA 
(A) Chemical structures of phosphatidylcholine (PC), lysophosphatidylcholine (LPC), 
and long-chain fatty acid (LCFA).  (B) Both E. coli and V. cholerae can utilize LCFA as 
the sole carbon source for growth, while only V. cholerae can utilize LPC. (C) Growth 
of E. coli and V. cholerae on LPC or LCFA as measured by colony counting. 
Quantification of bacterial growth was determined by plating assays. Viable colony-
forming unit counts show that E. coli fails to utilize LPC as the sole source of carbon. 
the fatty acid from the LPC molecule.  Similar results were obtained when the level of 
growth was measured by determining CFU of viable cells on agar plates (Fig. 2.1C).  
C 
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After observing this phenotype in V. cholerae El Tor, we expanded our testing to 
other Vibrio species, including V. alginolyticus, V. fischeri, V. harveyi, V. 
parahaemolyticus, and V. vulnificus.  Bacteria were grown under conditions similar to 
those of the initial experiments, with either 0.2% glucose (Fig. 2.2A) or 2 mM LPC (Fig. 
2.2B).  A defined salt-rich minimal medium was used for growth 
of V. fischeri and V. harveyi strains (see Materials and Methods). Interestingly, when 
grown with 2 mM LPC as the sole source of carbon, all strains were able to grow, with 
the exception of E. coli and V. fischeri (Fig. 2.2B).   
2.2.2 Bioinformatic analysis of Vibrio strains reveals a putative phospholipase in an 
operon with a FadL homolog 
Since the ability to use LPC as the sole carbon source was found in multiple 
species of Vibrio and not in others, a comparative genome search was performed using 
the String 9.0 database (http://string-db.org).  In all species capable of growth on LPC, an 
additional gene (vca0863 in V. cholerae) was found directly downstream of a FadL 
homolog (gene vca0862 in V. cholerae) (Fig 2.3).  A similar genetic organization was 
conspicuously absent from the V. fischeri genome.  Because only those bacterial strains 
that contained this putative operon were capable of growth on LPC, it suggested 
that vca0863 might be involved in the LPC growth phenotype.  Interestingly, VcA0863 is 
annotated as a putative lipase (Uniprot Q9KL83 [http://www.uniprot.org]; GenBank 
accession no. AAF96761.1 [http://ncbi.nlm.nih.gov]) and has an N-terminal lipoprotein  
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Figure 2.2 Growth of Vibrio species on various carbon sources 
(A) Growth of different Vibrio species and E. coli K-12 using glucose as the sole carbon 
source. Cultures of V. cholerae, V. alginolyticus, V. vulnificus, and V. 
parahaemolyticus were grown along with E. coli in minimal medium containing 0.2% 
glucose. V. fischeri and iwere grown in a high-salt defined minimal medium with 0.2% 
glucose. (B) All Vibrio species tested were able to use LPC as the sole carbon source for 
growth, with the exception of V. fischeri.  
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Figure 2.3 Genomic organization of FadL and VolA (VcA0863) homologs in various 
Gram-negative species 
All Vibrio species possess homologs of vc1042, vc1043, and vca0862 (encoding FadLs), 
and with the exception of V. fischeri, all also contain a homolog of vca0863. E. coli  has 
only a single homolog of FadL and no homolog of VolA. 
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signal sequence.  VcA0863 shows strong homology to pfam12262, having the known 
lipase amino acid sequence motif Gly-Xaa-Ser-Xaa-Gly (76).  This motif, containing a 
catalytic serine, has been identified in lipases derived from other aquatic organisms (76) 
and could potentially act in a similar manner in V. cholerae.  A non-aspartate residue is 
present in the +2 position after the signal peptide cleavage site, and based upon rules 
governing lipoprotein sorting and localization, the protein should be localized to the outer 
membrane (77). 
2.2.3 The genes vca0862 and vca0863 are cotranscribed in V. cholerae 
The intergenic region between the genes vca0862 and vca0863in 
all Vibrio species was between 16 and 23 bp.  To confirm that the FadL homolog 
(encoded by vca0862) and the phospholipase (encoded by vca0863) are encoded in an 
operon, RNA was purified from wild-type V. cholerae grown in minimal medium 
supplemented with glucose or glucose and LPC.  cDNA was generated and amplified by 
primers designed for internal regions of vca0862, vca0863, or a region spanning 400 
bases centered on the intergenic region (Fig. 2.4A).  Genomic DNA from wild-
type V. cholerae was used as a positive control.  PCR products were observed for the 
internal regions of the individual genes under both conditions: a 200-bp band 
representing vca0862 and a 165-bp band representing vca0863 (Fig. 2.4B).  The presence 
of LPC in the growth medium was not required for gene transcription compared to the 
glucose control.  A 430-bp band, generated from the intergene-spanning primers, 
confirms that vca0862and vca0863 are cotranscribed.   
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Quantitative reverse transcription-PCR (qRT-PCR) was performed to determine the 
expression profiles of vca0862 and vca0863 in wild-type bacteria grown in the presence 
of glucose, LPC, or glucose and LPC together.  The relative expression of both genes was 
measured as a ratio compared to expression for the glucose-only control.  Results showed 
that there was no statistically significant difference in the expression 
of vca0862 and vca0863 when LPC was added to the glucose control (Fig. 2.4C).  
However, when the strain was grown with LPC as the sole carbon source, expression of 
the genes increased dramatically, with that of vca0862 increasing ~25-fold and that 
of vca0863 increasing ~18-fold compared to expression for the glucose control.  Analysis 
of the vca0862promoter region using a footprinting algorithm (78) revealed binding sites 
for both cAMP receptor protein (CRP) and FadR.  E. coli CRP is a transcriptional 
activator that binds to DNA in a complex with cyclic AMP (cAMP); in the presence of 
glucose, levels of cAMP are decreased and CRP does not bind to the DNA (79, 80).  
FadR is a repressor of many fatty acid metabolism genes, including fadL, and is inhibited 
by binding coenzyme A (CoA)-activated fatty acids (50).  Thus, in the presence of 
glucose, both genes could be downregulated due to a lack of active CRP; this is 
consistent with the upregulation that is observed in cultures grown with LPC as the sole 
carbon source.  Additionally, for growth in succinate (Fig. 2.4D), this downregulation is 
abrogated, and growth with both succinate in the presence of LPC and LPC only shows 
an upregulation of vca0862 and vca0863 compared to findings for a succinate-only 
control.  This upregulation in the presence of LPC could also be due in part to a lack of 
downregulation by FadR because of its inhibition by LPC-derived fatty acids. 
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Figure 2.4 Organization and expression of fadL (vca0862) and volA (vca0863) 
(A) The genetic organization of vca0862 (FadL) and vca0863 (VolA) in V. cholerae, 
along with primer extension locations used in RT-PCR.  (B) RT-PCR of vca0862 and 
vca0863 show that the genes are cotranscribed and basal levels of expression are 
independent of the presence of LPC.  A genomic DNA template was used to confirm the 
amplified product sizes, and cDNA without reverse transcriptase (-RT) was used as the 
negative control verifying DNA-free RNA. (C) qRT-PCR data of the expression of 
vca0862 and vca0863 grown with glucose and/or LPC. When growth was in minimal 
medium containing LPC as the sole carbon source, expression of vca0862 and vca0863 
increased 25- and 18-fold, respectively, compared to expression for a glucose-grown 
control. (D) qRT-PCR data of the expression of vca0862 and vca0863 grown with 
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succinate and/or LPC. Growth in LPC displayed an upregulation of both vca0862 and 
vca0863 compared to a succinate-grown control. 
2.2.4 vca0863 is necessary for utilization of lysophosphatidylcholine 
After identification of an operon containing a phospholipase and an outer 
membrane fatty acid transporter, we investigated whether bacterial growth on LPC was 
dependent upon expression of vca0863.  When a vca0863-deficient V. cholerae strain 
was incubated with LPC as the sole carbon source, we found that it failed to grow (Fig. 
2.5A).  Growth on LPC is restored when vca0863 was expressed in trans from a low-
copy-number vector (pVcA0863).  However, the doubling time for the complemented 
strain was decreased ~3-fold compared to that for the wild type and may arise from 
increased release of LCFA from LPC by the lipase activity. 
Although E. coli K-12 is unable to grow on LPC, heterologous expression of 
VcA0863 in E. coli conferred growth on LPC (Fig. 2.5B).  However, expression of 
VcA0863 in which the amino acid glycine at position 20 is replaced with an aspartate 
residue (VcA0863-G20D) does not support growth.  Based upon the rules of lipoprotein 
sorting, replacement of the glycine residue with an aspartic acid in the +2 position after 
the lipoprotein signal sequence would result in mislocalization of VcA0863 to the inner 
membrane (77).  These results suggest that expression of VcA0863 is necessary for the 
bacterium to utilize lysophospholipids from the environment and that the protein must be 
localized to the outer membrane. 
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Figure 2.5 Expression and proper localization of VcA0863 is required for utilization of 
LPC as the sole carbon source 
 
(A) Growth of wild-type V. cholerae, vca0863 transposon mutant, and the complemented 
mutant on LPC. (B) Growth of wild-type E. coli and E. coli containing either pVcA0863 
or pVcA0863-G20D on glucose, LCFA, or LPC.   
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2.2.5 Strains expressing vca0863 modify their membrane phospholipids using the 
fatty acyl moiety of lysophosphatidylcholine 
Previously, we reported that V. cholerae underwent substantial membrane 
remodeling by incorporating long-chain fatty acids from its surrounding environment.   
Here, we asked if membrane remodeling also occurred in the presence of 
lysophospholipids.  Cultures of wild-type V. cholerae El Tor O1, the vca0863 mutant 
strain, and the complemented mutant were grown in defined minimal medium containing 
2% glucose and 32Pi in the presence of LCFA or LPC.  Wild-type E. coli K-12 was 
included as a negative control.  32P–labeled phospholipids were extracted and analyzed 
by thin-layer chromatography (TLC) (Fig. 2.6).  By using commercially available 
exogenous lipid sources with acyl chains that cannot be generated by the bacteria de 
novo, we can monitor the ability of the bacteria to utilize the exogenous lipid in the  
phospholipid biosynthesis pathway by TLC.  Here, we grew cultures in the presence of a 
mixed sample of either long-chain fatty acids or LPC, predominantly consisting of 18:2 
and 18:3 acyl chains; V. cholerae does not synthesize either of these chains de novo (81).  
When all three strains were grown in LCFA and 2% glucose, an upwards shift in mobility 
could be observed in all three of the major phospholipids (Fig. 2.6A), consistent with 
incorporation of the exogenous LCFAs into phospholipids. When the cultures were 
grown with glucose and LPC, only strains expressing vca0863 showed the same upward  
shift in mobility.  The lack of a shift in the mobility pattern in wild-type E. coli and the 
vca0863 transposon mutant is consistent with a requirement for VcA0863 expression to 
liberate the fatty acid from the LPC molecule. 
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We performed liquid chromatography/electrospray ionization (ESI)-tandem mass 
spectrometry on lipids extracted from wild-type V. cholerae, a vca0863-deficient mutant 
of V. cholerae, and the complemented mutant.  Each of the major phospholipids was 
analyzed.  Analyses of spectra revealed distinct differences between the vca0863 
transposon mutant and the wild-type and complemented strains.  Specifically, results 
from the Lipid Maps Structure Database prediction algorithm 
(http://www.lipidmaps.org/) showed several phospholipid species corresponding to 
phosphatidylglycerol containing C18:2 and C18:3 that were present only in spectra for wild-
type or complemented V. cholerae grown in the presence of C18:2/18:3-LPC (Fig. 2.7A).  
Masses of A phosphatidylglycerol [M-H]1− ion peak with mass of 743.469 (Fig. 2.7A) in 
the wild-type or complemented strain was selected for tandem mass spectrometry.  
Collision-induced dissociation of the m/z743.469 ion revealed two phosphatidylglycerol 
species containing C18:2/C16:1 or C18:3/C16:0, confirmed by the presence of peaks 
at m/z 277.219 and 279.238, which correspond to C18:3 and C18:2 acyl chains, respectively 
(Fig. 2.7B). phospholipid species specific to LPC growth are highlighted red in Figure 
2.7.   Similar phenotypes were observed for phosphatidylethanolamine and cardiolipin 
species, indicating that lipids derived from LPC can be used both for nutrition and for 
remodeling of all of the membrane phospholipids (Fig 2.8 & 2.9). 
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Figure 2.6 TLC confirmation of incorporation of LPC-derived fatty acids into membrane 
phospholipids of V. cholerae 
Thin-layer chromatography of LCFA- and LPC-grown cultures of V. cholerae.  V. 
cholerae strains, including the wild-type, the vca0863 transposon mutant, and the 
vca0863-complemented mutant, were grown in the presence of 2 mM LCFA or LPC 
containing 18:2 and 18:3 unsaturated carbon chains that V. cholerae cannot synthesize de 
novo. All three strains show a shift in mobility for each of the major phospholipids when 
treated with LCFA, as expected. When treated with the LPC mix, only strains expressing 
vca0863 (wild type and complemented mutant) showed a similar shift, indicating 
that vca0863 is required for generating LPC-derived fatty acid. Guidelines have been 
included for comparison on mobility shifts. 
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Figure 2.7 Mass spectrometric analysis of LPC-derived LCFA incorporation into  
phosphatidylglycerol of V. cholerae 
A) Phosphatidylglycerol was isolated from wild-type, vca0863 mutant, 
and vca0863 mutant complement strains of V. cholerae and analyzed by liquid 
chromatography/ESI-mass spectrometry. Strains that express vca0863 showed a unique 
set of peaks (shown in red) corresponding to weights of phospholipids that have acyl 
chains with unsaturations matching those in the LPC mix. These peaks were absent from 
the vca0863 mutant. (B) Tandem mass spectrometry (MS/MS) of a PG peak with an m/z 
of 743.469 found only in vca0863-expressing strains.  MS/MS showed that C18:2 and C18:3 
acyl chains that originate with exogenous LPC are incorporated into the V. cholerae 
membrane. 
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Figure 2.8 Mass spectrometry of LPC-derived LCFA incorporation in 
phosphatidylethanolamine of V. cholerae 
Phosphatidylethanolamine (PE) was isolated from wild-type, vca0863 mutant, 
and  complemented strains of V. cholerae and analyzed. Strains that 
express vca0863 showed a set of peaks that indicate incorporation of LPC-derived LCFA 
(shown in red). These peaks were absent from the vca0863 mutant. 
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Figure 2.9 Mass spectrometry of LPC-derived LCFA incorporation in cardiolipin of V. 
cholerae 
Cardiolipin (CL) was isolated from strains of V. cholerae and analyzed via mass 
spectrometry. Strains that express vca0863 contained a set of peaks which incorporate 
LPC-derived LCFA (shown in red). These peaks were not present in the cardiolipin from 
the vca0863 mutant. 
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2.2.6 The vca0863 gene product is a surface-exposed lipoprotein 
In the course of this study, we observed that a fadL mutant of E. coli failed to 
grow using LPC as the sole carbon source when heterologously expressing vca0863 (Fig 
2.10).  Because FadL is responsible for the uptake of LCFAs, it is reasonable to assume 
that the breakdown of LPC occurs prior to entry into the cell.  This indicates that  
VcA0863 may be surface exposed.  To confirm localization of VcA0863, whole 
bacteria were labeled with an amine-reactive biotin (N-hydroxysuccinimide [NHS]-long-
chain [LC]-LC biotin), and the labeled proteins were visualized using a streptavidin 
horseradish peroxidase conjugate (Fig. 2.11) (82).  The large size and polar nature of the 
biotin compound prevent passage across the outer membrane, allowing selective labeling 
of surface-exposed proteins.  When whole cells were labeled, only minimal signal could 
be detected in the soluble fraction, indicating that the biotin compound failed to 
significantly penetrate the outer membrane (Fig. 2.11A). To determine if VcA0863 was 
surface exposed, a V. cholerae El Tor O1 vca0863-deficient strain was transformed with 
vectors expressing His-tagged variants of either vca0863 or vca0863 encoding the G20D 
replacement (vca0863-G20D).  Cells were also separately transformed with vectors 
containing an E. coli-derived β-lactamase (encoded by ampC) (83), serving as a negative 
control, or V. cholerae ompT, an outer membrane β-barrel acting as a positive control 
(84).  After labeling the V. cholerae strains with NHS-LC-LC biotin, cells were harvested 
and lysed, and polyhistidine tagged proteins were isolated using cobalt affinity resin and 
analyzed via Western blotting (Fig. 2.11B).  On the antibiotin blot, controls reflected the 
surface specificity of the biotin labeling.  For example, surface-exposed OmpT was 
efficiently biotinylated and produced a strong signal.  Periplasmic β-lactamase, however, 
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showed minimal labeling even though the protein is overexpressed, suggesting that NHS-
LC-LC biotin did not cross the outer membrane to a significant degree.  Also detected on 
the antibiotin blot was a prominent 83-kDa band representing VcA0863, indicating that it 
is surface exposed.  No signal could be detected for the mislocalized VcA0863-G20D 
mutant. 
In addition to using surface biotinylation, we independently confirmed that 
VcA0863 is surface exposed through the use of immunogold electron microscopy.  Wild-
type E. coli K-12 or wild-type V. cholerae El Tor expressing VcA0863 were incubated 
with polyclonal anti-VcA0863 antibodies followed by gold-conjugated goat anti-rabbit 
antibodies.  The labeled whole cells were then analyzed via electron microscopy.  
Both E. coli and V. cholerae cells expressing VcA0863 showed a considerable number of 
gold particles associated with the cell surface in comparison to strains lacking VcA0863, 
which showed no surface labeling (Fig. 2.12).  Together with the surface biotinylation of 
VcA0863, these data indicate a clear surface localization of the lipase.  Given that 
VcA0863 has a lipase domain, is required for growth on lysophospholipids, and is 
localized to the bacterial surface, we have named the vca0863 gene product VolA 
for Vibrio outer membrane lysophospholipase A. 
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Figure 2.10 FadL is required for use of LPC as a carbon source 
Wild-type E. coli and a fadL deletion strain containing pVcA0863 were assayed for 
growth on 0.2% glucose, 2 mM LCFA, or 2 mM LPC after 24 h. As predicted, when 
FadL is lost regardless of expression of VcA0863, no growth could be observed on 
LFCA. Only E. coli expressing both FadL and VcA0863 showed growth above 
background levels on LPC.  
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Figure 2.11 Biotin labeling of surface-exposed VcA0863 
(A) Antibiotin Western blot of soluble and insoluble protein fractions from either whole 
V. cholerae cells or cell lysates labeled with NHS-LC-LC-biotin. (B) SDS-PAGE and 
antibiotin Western blot of His-tagged VcA0863, β-lactamase, OmpT, and mislocalized 
VcA0863 affinity purified from cell extracts of biotin-labeled whole cells. Protein bands 
at ~81 kDa (VcA0863-His6 and mislocalized VcA0863-His6) and ~41 kDa (β-lactamase-
His6 and OmpT-His6) in size were observed in SDS-PAGE, establishing that all proteins 
were running according to their molecular masses. The antibiotin Western blot showed 
two proteins, an 81-kDa band representing wild-type VcA0863 and a 41-kDa band 
representing OmpT. The fact that VcA0863 was labeled with biotin strongly indicates 
that VcA0863 is surface exposed. OmpT was also labeled due to its exposure on the 
surface of the cell. Little or no signal could be detected for either β-lactamase or 
mislocalized VcA0863 due to lack of surface exposure. 
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Figure 2.12 Immunogold electron micrographs of E. coli and V. cholerae strains 
expressing vca0863 
Gold particles (examples are denoted with a red arrow) indicate the presence of surface-
exposed VcA0863. Both E. coli expressing vca0863 from the plasmid and wild-type 
V. cholerae showed gold particles associated with the surface of the cell, indicating that 
VcA0863 is exposed to the surface in both strains. Wild-type E. coli or the V. cholerae 
vcA0863 mutant failed to display any associated gold particles on the bacterial surface. 
Mean gold particle counts are reported with standard errors (n> 10); statistical 
significance was observed between results for strains expressing and not 
expressing vca0863. *, P < 0.0005, Mann-Whitney U test. 
 
Mean Bead Count/Cell 
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2.3 DISCUSSION 
This study demonstrates an unusual form of lipid utilization in the Gram-negative 
bacterium Vibrio cholerae.  In the course of its life cycle, V. cholerae experiences a 
variety of environments, from its planktonic existence in the ocean, living as aggregates 
associated with animal reservoirs in aquatic ecosystems, to infecting a human host.  
Concentrations of nutrients, ions, and salts vary significantly between these conditions, as 
does the presence of antimicrobial agents; because of this, V. cholerae has developed 
specific systems to adapt itself for survival.  One such system is the fatty acid uptake 
pathway, used to incorporate fatty acids from the environment directly into various 
metabolic pathways.  Previous experiments from our laboratory have shown 
that V. cholerae is capable of using very-long-chain fatty acids from the environment 
both as a carbon source and to remodel its membrane lipids; these fatty acids have not 
been shown to be used by other Gram-negatives.  This distinct uptake profile could be 
due to evolution of multiple homologs of FadL and FadD found only in V. cholerae and 
some related species.  Elaborating on the utilization of unconventional lipids by 
V. cholerae, the current work highlights the ability of V. cholerae to process 
lysophosphatidylcholine (LPC) for use in various metabolic pathways.  The ability to use 
LPC from its surroundings has advantages for V. cholerae fitness in terms of nutrient 
acquisition and environmental acclimatization; LPC-derived fatty acids can be used as a 
nutrient source, reducing the energetic needs of the cell, but they can also be used to 
remodel phospholipids.  By using environmental lipids to remodel the membrane 
architecture of the cell, V. cholerae could respond to membrane stress through 
homeoviscous adaptation, a mechanism by which bacteria can regulate their membrane 
fluidity when exposed to a new environment. 
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LPC and its progenitor phospholipids are commonly found in both aquatic 
environments and in human host.  In the ocean, V. cholerae associates with a variety of 
organisms, including zooplankton (85, 86), chironomid egg masses (87), flora (88), 
protozoa (89, 90), mollusks (91), and fish (92).  Phospholipids and lysophospholipids are 
present in and on these various reservoirs (93–96).  Secretion of a lecithinase 
in V. cholerae (97) could free the lyso derivative from phosphatidylcholine in the 
environment.  The ability of V. cholerae to use LPC as a carbon source provides a fitness 
advantage in nutrient-poor aquatic environments.  Furthermore, the ability to scavenge 
lysophospholipids may reach beyond the usage of LPC.  Other environmental lipids 
present in appreciable amounts could also be processed by VolA or VolA-like proteins. 
Once V. cholerae infects a human host, it is consistently exposed to phospholipids 
and their derivatives.  Through human pancreatic phospholipase A2 activity for both 
dietary and bile-sourced phospholipids, the human intestine has significant levels of 
lysophospholipids, with LPC as the predominant lipid (98).  V. cholerae can modify its 
membrane lipids using the fatty acid freed from LPC in a manner similar to that of 
exogenous fatty acid remodeling.  By breaking down the LPC that is present and altering 
its own membrane phospholipids to resemble the host, V. cholerae could protect itself 
against membrane stress.  More importantly, LPC has been shown to be involved in 
several proinflammatory signaling pathways (99, 100), generation of reactive oxygen 
species (101), and indirect antimicrobial effects on Gram-negatives (102, 103).  A 
secondary effect of this utilization may be to reduce the local concentration of LPC, thus 
circumventing host defenses and reducing bacterial clearance. 
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The importance of lipid utilization in bacteria is not fully understood.  While fatty 
acid uptake has been investigated, few data are available concerning alternate lipid 
sources.  This study is just one example of how other lipids might be used via 
undiscovered enzymes that work in conjunction with known uptake pathways.  Other 
lipids may play similar roles in nutrition and membrane remodeling in a manner similar 
to fatty acids and LPC.  Cholesterol, for example, has been shown to have significant 
effects on membrane strength when incorporated into the human pathogen Helicobacter 
pylori (104). It also plays a role in nutrition in Mycobacterium tuberculosis (105).  It is 
unclear if lipid uptake plays as substantial a role in other organisms besides Gram-
negative bacteria.  Uptake of fatty acids has been observed in Gram-positive organisms 
(106), but it is unknown if the mechanism of uptake is similar to that of Gram-negative 
species. 
We propose a model for the mechanism of LPC utilization (Fig. 2.13).  In this 
model, VolA acts on LPC prior to its passage through FadL, supported by the fact that 
growth on LPC as the sole carbon source is dependent on expression of FadL (Fig. 2.9).  
This model is particularly intriguing because there are currently only a few surface-
exposed lipoproteins in Gram-negative bacteria: TraTp (107), a component of the F sex 
factor, WZAK30 (108), a multimeric pore-forming complex involved in K30 capsular 
polysaccharide expression, and CsgG (109), a member of the secretion apparatus of curli 
fibers in the Enterobacteriaceae.  Additionally, the most abundant protein in E. coli, Lpp, 
was recently identified by the Silhavy group as being expressed as a surface-exposed 
lipoprotein (82).  Lpp has been shown to have two forms: a peptidoglycan-bound form 
and a “free” form which occur in a ~1:2 ratio.  Cowles et al. (82) demonstrated that 
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nearly all of the free form of Lpp is localized to the surface of the outer membrane 
of E. coli.  While these are several examples of surface-exposed lipoproteins, there is a 
noticeable lack of discovered lipoprotein enzymes.  Pullulanase, a starch-debranching 
lipoprotein that is exported to the outer surface of Klebsiella species and subsequently 
released into the growth medium, is one of the only known examples of a surface 
lipoprotein with enzymatic function (110).  The protein described in this work is an 
instance of a surface-exposed lipase illuminating how lipoproteins can play a role in 
extracellular enzymatic mechanisms. 
It is currently unknown how the protein identified in this study is transported to 
the surface of V. cholerae.  VolA is likely shuttled through the Lol system (111), 
especially since mutation of the +2 residue after the lipoprotein signal sequence can 
disrupt localization (Fig. 2.10).  Since the Lol transport machinery ends at the periplasmic 
face of the outer membrane, how VolA reaches the outer surface of the cell (Fig. 2.12) is 
unknown.  The fact that VolA can be properly expressed in E. coli, combined with the 
recent discovery that Lpp is also surface exposed, indicates that 
both E. coli and V. cholerae express the machinery required to transport lipoproteins to 
the outer surface.  The easily observed growth phenotype associated with the utilization 
of lysophospholipids presents an opportunity to identify additional machinery required 
for the transport of VolA to the bacterial surface. 
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Figure 2.13 Proposed mechanism for VolA-dependent utilization of lysophospholipids 
Exogenous LPC is initially cleaved by the surface-exposed lipoprotein VolA (VcA0863). 
One of the V. cholerae homologs of FadL (encoded by vc1042, vc1043, or vca0862) can 
then transport the free fatty acid. Following transport across the periplasm and the inner 
membrane, the fatty acid is converted to an acyl-CoA by FadD. The activated fatty acid 
can be utilized for phospholipid biosynthesis or used as a carbon source for the bacterial 
cell. 
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The current study continues to highlight the importance of lipid utilization by Gram-
negative bacteria.  Vibrio species may have evolved this adaptation as an efficient means 
for both maintenance of the membrane and carbon source acquisition.  The ability to 
exploit exogenous lipids in different environmental reservoirs would allow the bacterium 
to adopt a phospholipid profile that reflects the fatty acid composition of its surrounding 
environment, perhaps as a mechanism of homeoviscous adaptation to survive membrane 
stress.  The roles that VolA and membrane remodeling play in the adaptation 
of V. cholerae to diverse environments are currently under investigation. 
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Chapter 3: Characterization of the V. cholerae VolA Surface-Exposed 
Lipoprotein Lysophospholipase2  
3.1 INTRODUCTION 
Recent work from our laboratory revealed the presence of a unique membrane-
anchored lipase – VolA – localized on the surface of the V. cholerae (112).  We 
demonstrated that VolA is required for growth when lysophosphatidylcholine (LPC) (Fig. 
2.5) serves as the sole carbon source.  We hypothesized that VolA could cleave 
exogenous lysophosphatidylcholine into long-chain fatty acid (LCFA) derivatives (Fig. 
3.1), allowing them to be brought into the cell via a co-expressed fatty acid transporter, 
FadL.  This data, taken together with the presence of a conserved lipase domain (113) 
identified in V. cholerae VolA and the inability of wild-type V. cholerae to grow on 
phosphatidylcholine as a sole carbon source, points towards VolA acting as a 
lysophospholipase in vivo.   
Phospholipases are members of the acylhydrolase family of enzymes, acting on 
ester bonds in phospholipid targets (114).  The structure and function of such 
acylhydrolases are conserved and have been well studied.  All contain a characteristic 
fold (115, 116), sharing a conserved lipase motif (113).  In our previous work (112), we 
noted VolA contains this conserved motif, which strongly implicates it as a lipase.  
Phospholipases vary in terms of their site of action on the phospholipid.  Some target 
phosphate bonds, while others hydrolyze bonds between the glycerol moiety and the acyl 
chains.  Most microbial lysophospholipases hydrolyze the ester bond between the acyl   
                                                
2 Large portions of this chapter have been previously published (Pride A.C., Guan Z., and Trent M.S. 
(2014) Journal of Bacteriology 196:1619-26.) 
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Figure 3.1 Proposed reaction scheme for VolA 
Structures of lipids and proposed reaction for the lysophospholipase activity of VolA. 
VolA is predicted to act as a lysophospholipase A, hydrolyzing the ester bond between 
the fatty acid moiety and the glycerophosphocholine (GPC) head group. The red asterisk 
denotes the position of the 14C label on the LPC substrate used during in vitro assays.  
 
 
 
 
 
* 
* 
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chain and the polar head group, releasing a free fatty acid (117).  It is likely that VolA 
functions similar to existing bacterial lysophospholipases, given that V. cholerae can 
survive on lysophosphatidylcholine, but not phosphatidylcholine, as the sole carbon 
source.  It is unknown whether the enzymatic activity of VolA requires a cofactor, as 
both metal-dependent and metal-independent phospholipases have been identified in a 
variety of bacterial species (118, 119).   
VolA contains a predicted N-terminal lipoprotein signal peptide.  Previously, we 
demonstrated VolA localizes to the surface of V. cholerae (112), suggesting VolA could 
be anchored to the outer leaflet of the outer membrane by N-terminal lipidation.  
However, physical characterization of VolA is required to confirm its status as a 
lipoprotein.    
Herein, we describe the biochemical characterization of VolA.  Elucidation of the 
enzymatic activity of VolA will aid our understanding of how it contributes to bacterial 
fitness in both aquatic and host environments.  This work confirms that VolA is both a 
lipoprotein and hydrolyzes lysophosphatidylcholine substrates in a metal-independent 
manner.  We show that a conserved serine within a conserved Gly-Xaa-Ser-Xaa-Gly 
lipase motif is required for enzymatic activity.  Additionally, we demonstrate that a 
homolog of volA found in the aquatic pathogen Aeromonas hydrophila is able to 
complement a VolA mutant of V. cholerae.  This suggests that lipase activity may be 
conserved across the VolA homologs found in various gram-negative aquatic organisms.  
VolA is a novel lysophospholipase, the first surface-anchored lipase identified in gram-
negative organisms.  Characterization of such an enzyme will reveal its larger role in 
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microbial metabolism and survival, as well as describe the features of a potentially new 
lipase class.   
3.2 RESULTS 
3.2.1 Membranes containing VolA are capable of hydrolyzing 
lysophosphatidylcholine.   
To determine if VolA displays lysophospholipase activity, bacteria (strains listed 
in Table 5.1) were grown in LB, and the washed membrane fraction was isolated as 
previously described (120).  Membranes were assayed for possible phospholipase activity 
using C16:0 L-1-[palmitoyl-1-14C] (111,000 cpm nmol-1) (PerkinElmer) as the substrate 
and the reaction products analyzed by thin-layer chromatography (Fig. 3.2).  When wild-
type or VolA-complemented V. cholerae membranes were assayed, the TLC results 
showed two spots: one with an Rf of 0.09, matching that of intact (C16:0)-LPC and one 
with an Rf of 0.49, running at the same Rf with a 3H-palmitate control.  We consider this 
spot to be freed C16:0 LCFA.  Membranes derived from bacteria expressing VolA 
display the released fatty acid, whereas membranes isolated from a volA mutant fail to 
hydrolyze LPC.  Also, membranes isolated from the complemented mutant showed 
increased production of the free fatty acid reaction product with wild-type membranes 
yielding a specific activity of 3.1 nmol min-1 mg-1 175 and membranes over-expressing 
VolA showing a 5-fold increase in lipase activity (15.1 nmol min-1 mg-1).  Together, this  
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Figure 3.2 Lysophospholipase activity of VolA-containing membranes 
V. cholerae membranes cleaved 14C-labeled C16:0 lysophosphatidylcholine in a VolA 
expression-dependent manner. The lysophospholipid substrate and the LCFA reaction 
product were separated by TLC and are indicated. 3H-palmitate was used as a TLC 
standard.  
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data confirms the expected the reaction scheme for VolA lysophospholipase activity 
displayed in Figure 3.1.    
3.2.2 Purification of VolA lipoprotein.   
Bioinformatic analysis revealed a putative lipoprotein signal sequence within 
VolA.  To investigate the physical and biochemical properties of purified VolA, the 
vca0863 gene encoding VolA was cloned into pET21a with a C-terminal 8x histidine 
fusion and expressed in E. coli BL21 (DE3).  The protein was solubilized and initially 
purified using affinity chromatography, followed by a second round of purification using 
a gel filtration column.  A purified protein of ~83 kDa was observed on SDS-PAGE, 
corresponding to 8x His-tagged VolA (Fig. 3.3A).  In order to establish VolA as a 
lipoprotein, purified protein was analyzed via liquid chromatography/tandem mass 
spectrometry.  The expected mass of 8x His-tagged VolA as predicted by the Scripps 
Protein Calculator is 82702.5 m/z (http://www.scripps.edu/cgi-bin/cdputnam/protcalc3).  
The de-convoluted spectra showed a predominant peak with a mass of 83521.0 m/z  (Fig. 
3.3B), a difference of ~818.53 m/z.  This mass difference is likely the tri-acyl 
modification (predicted mass of 818.77 m/z) that is covalently added to the N-terminus of 
gram-negative lipoproteins.  Prediction of the VolA N-terminal cysteine modification 
(Fig. 3.3C) shows that addition of a C16:0/C18:1 diacylglycerol via a thioether bond and 
a C16:0 fatty acid via an amide linkage would result in the observed mass difference.  
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Figure 3.3 Purification and mass spectrometry of the VolA lipoprotein 
(A) SDS-PAGE of purified VolA (~82 kDa protein).  (B) Mass spectrometry analysis 
showed a mature protein with a predominant mass of 83521.0, a difference of 818.53 
from the expected mass.  (C) Predicted N-terminal modification of the VolA lipoprotein.  
Tri-acylation with two C16:0 and one C18:1 fatty acids (predicted mass 818.77) would 
result in the observed mass of mature VolA.  The lipid moiety has been highlighted in 
red. 
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3.2.3 VolA acts as a lysophospholipase in vitro in a metal-independent manner 
  In order to establish if VolA was responsible for the lysophospholipase activity 
observed in the membranes of wild-type and complemented strains, purified VolA was 
assayed for lysophospholipase activity using [14 199 C]-labeled C16:0 LPC.  Similar to 
TLC data from assaying isolated membranes, there were two reaction products (Fig. 3.4).  
One, with an Rf of 0.09, ran equidistant with the no-enzyme LPC control.  The second 
reaction product, with an Rf of 0.49, was liberated C16:0 LCFA confirming that purified 
VolA acts as a lysophospholipase in vitro.  The purified enzyme had a specific activity of 
404 nmol min-1 mg-1, a ~128-fold increase over the in vitro activity of purified wild-type 
membranes.    
Because many bacterial phospholipases are metal-dependent, with Ca2+ or Mg2+ 
being common requirements, we sought to identify if VolA lipase activity displayed 
similar requirements.  To further characterize the lysophospholipase activity of purified 
VolA, the enzymatic assay conditions were altered to include either metal ions or metal 
ion chelators.  Both EDTA and EGTA were added to the reaction, either separately or 
together, to test whether loss of metal ions in the active site of VolA might have an 
adverse effect on the activity of the enzyme (Fig. 3.4).  While the addition of EDTA 
alone had no effect on the lipase activity of VolA, addition of EGTA by itself or in 
combination with EDTA caused a slight increase in the conversion of LPC to the LCFA 
product.  When metal ions were supplemented in the reaction condition, there was no 
effect on the conversion of LPC to LCFA as compared to enzyme alone (Fig. 3.4).  Taken   
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Figure 3.4 VolA is a metal-independent lysophospholipase 
Purified VolA retained wild-type activity in the presence of the metal ion chelators 
EDTA and EGTA.  Addition of supplemental metal ions (Ca2+ and Mg2+) had no effect 
on the activity of VolA. Concentration of each additive is indicated. 
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together, these results suggest that VolA lysophospholipase activity does not require the 
presence of metal ions.    
3.2.4 Enzymatic parameters of purified VolA  
In vitro assays were performed to establish the parameters of VolA activity (Fig. 
3.5).  Enzymatic activity was measured via quantitative TLC.  Percent conversion of LPC 
to LCFA was calculated using densitometry to quantitate the LPC and LCFA spots.  We 
show VolA activity is linear with time (Fig. 3.5A), which is characteristic of an enzyme.  
We also conducted temperature and pH dependence of VolA.  Dependence on 
temperature was established via a step-gradient from 4˚C to 42˚C (Fig. 3.5B), with VolA 
showing the highest amount of LPC conversion at 37˚C.  Finally, the pH-dependence of 
VolA was determined by varying the pH of the assay condition (Fig. 3.5C).  The pH was 
varied between 4 and 9; VolA shows optimal enzymatic activity at a pH of 8.0.  
3.2.5 A catalytic serine within a conserved lipase domain is required for VolA 
activity   
Previously, a well-conserved Gly-Xaa-Ser-Xaa-Gly lipase domain was identified 
within the sequence of VolA (112).  When the sequences of VolA homologs were 
analyzed, this domain was invariably conserved (Fig. 3.6A); the central serine is 
presumed to function in a catalytic Asp-His-Ser triad (121).  We sought to determine if 
this serine was essential to the enzymatic activity of VolA.  Wild-type VolA was 
mutagenized using site-directed mutagenesis and the putative catalytic serine was altered 
to either an alanine (VolA-S551A) or a threonine (VolA-S551T).  Alanine was selected 
because it can maintain the protein carbon backbone while eliminating any potential side- 
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Figure 3.5 Enzymatic parameters of VolA in vitro 
(A) Conversion of 14 535 C-LPC into C16:0 LCFA at different times under standard 
conditions. (B) Assay of VolA activity at varying temperatures. (C) VolA activity as a 
function of pH.  
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chain interactions, thus eliminating any active site participation; threonine was selected 
because it most closely resembles the biochemical character of serine.  Mutant protein 
expression was confirmed by western blot using an anti-VolA polyclonal antibody (Fig. 
3.6B).  Initially, volA mutant strains of V. cholerae carrying a vector control, pVolA, 
pVolA-S551A, or pVolA-S551T were grown in the presence of 2mM C16:0 LPC.  When 
grown with LPC as the sole carbon source (Fig. 3.6C) only the mutant complemented 
with the wild-type pVolA plasmid was able to grow.  This indicates that the presence of a 
serine within the Gly-Xaa-Ser-Xaa-Gly motif is required for the catabolism of LPC. 
 To confirm the conserved serine is required for proper active site function, 
membranes isolated from the V. cholerae volA mutant expressing mutagenized copies of 
volA were assayed for lipase activity (Fig. 3.6D).  Both the S551A and S551T mutants 
fail to cleave the labeled LPC molecule.  This data, combined with the failure of the 
serine mutants to complement the volA mutant growth phenotype, strongly suggests that 
serine 551 acts as a nucleophile within the VolA active site.   
3.2.6 A VolA homolog from the aquatic pathogen Aeromonas hydrophila can 
complement a V. cholerae volA mutant 
In our previous study (112), homologs of VolA were identified in various Vibrio 
species; further exploration revealed homologs in several other marine bacteria (Fig. 
3.6A, Table 3.1).  Each of these homologs contain the conserved lipase motif found 
within VolA and a predicted lipoprotein signal sequence (122).  The lipoprotein signal 
sequences all include a non-aspartate amino acid in the +2 position after the cleavage site, 
and based upon the rules of lipoprotein sorting predicts an outer-membrane association  
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Figure 3.6 VolA requires a catalytic serine within a conserved lipase motif for activity 
(A) Alignment of the protein region containing the conserved lipase motif Gly-Xaa-Ser-
Xaa-Gly (residues 549-553 in V. cholerae VolA). Homologs of VolA were identified in 
Vibrio species and other marine organisms. (B) Anti-VolA western blot of cell lysate 
expressing wild-type VolA or one of the VolA mutants (S551A, S551T). Mutant proteins 
expressed strongly despite mutation of the active-site serine. (C) Growth of the V. 
cholerae volA mutant expressing either wild-type VolA or VolA catalytic serine mutants 
on LPC as the sole carbon source. Both S551A and S551T mutants failed to grow using 
LPC. (D) Lysophospholipase assay of membranes expressing either wild-type VolA or 
VolA S551  S551T mutants. 
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Table 3.1 Homologs of VolA 
 
 
 
 
 
 
 
(77) similar to VolA.  The Pla-1 protein found in the aquatic pathogen Aeromonas 
hydrophila displays the closest identity to VolA (BLAST E value = 5e-100, identity = 
33%) and was predicted to be a secreted lipase based on bioinformatic analysis (123).  
We wanted to determine if Aeromonas Pla-1 could functionally complement the Vibrio 
volA mutant (Fig. 3.7).  Interestingly, expression of Pla-1 restored growth of the V. 
cholerae mutant on LPC to wild type levels (Fig. 3.7A).  Also, membranes isolated from 
the pla-complemented volA mutant showed robust levels of lysophospholipase activity 
(Fig. 3.7B) indicating that the Aeromonas enzyme remains associated with the bacterial 
surface similar to what occurs in Vibrio.    
 
3.3 DISCUSSION  
There have been very few surface-anchored lipoproteins identified in gram-
negative bacteria (82, 107–109).  Pullulanase, expressed by Klebsiella pneumoniae, is the 
first record of such a protein acting as an enzyme (110).  VolA is novel, as it is the first 
example of a Gram-negative bacterial surface-anchored lipoprotein functioning as a  
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Figure 3.7 Expression of Aeromonas hydrophila Pla is capable of complementing the V. 
cholerae volA mutant 
(A) Expression of A. hydrophila pla successfully complemented the growth phenotype of 
the V. cholerae volA mutant using LPC as the sole carbon source. (B) Lysophospholipase 
activity of membranes of the V. cholerae volA mutant expressing A. hydrophila Pla. TLC 
results show that expression of Pla in the volA mutant successfully restores 
lysophospholipase activity. 
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lipase.  VolA plays a role not only in the metabolism of extracellular lipid substrates (i.e. 
lysophospholipids), but also in the incorporation of environmental lipids into the bacterial 
membrane.  Previously, our laboratory demonstrated that V. cholerae was capable of 
incorporating a diverse array of LCFAs from the extracellular milieu into phospholipids 
thereby influencing the bacterial membrane architecture (57).  V. cholerae were able to 
incorporate very long (C22) host-derived acyl chains containing multiple unsaturations 
while other gram-negatives including E. coli and Salmonella enterica could only process 
shorter (C20) acyl chains.  This expanded uptake profile could be attributed to the fact 
that V. cholerae contains three homologs of FadL, an outer membrane fatty acid 
transporter (124).  Indeed, our recent work showed that VolA is co-expressed with a 
FadL homolog.  It is likely that the lysophospholipase activity of VolA is coupled to the 
uptake of LPC-derived LCFAs which can then be incorporated into the bacteria 
membrane.  Bacteria have been shown to use membrane remodeling as a survival 
adaptation, making it likely that VolA plays a similar role during infection of the host 
(125, 126).  We observed that VolA is well-conserved across many Vibrio species 
prompting us to further characterize this intriguing protein.  The enzyme is conserved not 
only in other Vibrio species but also in other gram-negative bacteria (Table 3.1).  Here, 
we confirm that the homolog produced by Aeromonas hydrophila, which has the closest 
identity to VolA among the different aquatic homologs, can successfully complement a 
volA V. cholerae mutant.   
In this work we confirm that VolA is indeed a lipoprotein.  Mass spectrometry  
results show VolA is modified with both a diacylglycerol and a fatty acid, with saturated 
acyl chains of C16 and C18:1 (Fig. 3.3); this follows the canonical modification of 
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bacterial lipoproteins (127, 128).  The predicted modification is likely one of a mixture of 
species, following the distribution of acyl chains found in the phospholipids of E. coli 
(129).  V. cholerae shows a similar fatty acid profile, with the predominant phospholipids 
bearing C16:0 and C18:1 fatty acyl chains (130).   Bacterial lipoproteins are sorted based 
on the residue in the +2 position that occurs after the N-terminal peptide has been cleaved 
(77).  VolA has a non-aspartate residue in the +2 position (112) and therefore, is sorted to 
the outer membrane.  However, how surface-anchored lipoproteins like VolA are 
localized to the outer leaflet of the outer membrane is currently unknown.  It remains a 
possibility that transport machinery, such as the PulD-PulS secretin channel found in 
Klebsiella that functions to export pullulanase (131), the Bam complex involved with the 
transport of outer membrane β-barrels (132), or an unknown dedicated chaperone exists 
in the outer membrane to fully process surface-exposed lipoproteins.   
We also show that pure VolA possesses enzymatic activity acting as a 
lysophospholipase.  Previous studies have shown that a conserved serine commonly 
involved in an Asp-His-Ser triad (133) acts as the catalytic residue (134).  We show a 
conserved serine at position 551 within VolA is absolutely essential to its activity (Fig. 
3.6), implying this residue functions as the active site nucelophile.  VolA displays other 
potential lipase-related features.  Many lipases have a motif that indicates the structure of 
the oxyanion hole.  A conserved Gly-Gly-Gly-Xaa or Gly-Xaa sequence exists between 
secondary structural elements of the lipase, where the first Gly residue or the Xaa residue 
respectively functions as the oxyanion hole, contributing a hydrogen atom to help 
stabilize the reaction intermediate (135).  In VolA, the Gly-Gly-Gly-Xaa motif is absent.   
Previously it was observed that lipases with the Gly-Gly-Gly-Xaa motif act upon short-
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chain substrates, while Gly-Xaa motif-containing lipases act on medium- and long-chain 
substrates (134).  VolA follows this convention, capable of hydrolyzing C16:0- and 
C18:0-lysophospholipids.  In vitro assays were used to establish the parameters for VolA 
enzymatic activity.  Initially, we wanted to establish if VolA had metal ion dependence.  
While both metal-dependent and metal-independent bacterial phospholipases have been 
characterized (118, 119), there is a strong preponderance of metal-dependent enzymes.  
Enzymatic assays showed VolA is capable of cleaving LPC into free C16:0 fatty acid and 
glycerophosphocholine in the presence of metal chelators EDTA and EGTA (Fig. 3.4).  
This, along with data showing no appreciable increase when metal ions are 
supplemented, implies VolA is a Ca2+- and Mg2+-independent lysophospholipase.  This is 
intriguing because while several mammalian metal-independent phospholipases with 
lysophospholipase activity have been identified (136), no such metal-independent 
lysophospholipases have been identified in bacteria.   
In addition to displaying Ca2+- and Mg2+-independence, we also assayed other 
parameters of VolA enzymatic activity (Fig. 3.5).  VolA shows both a temperature and 
pH dependence.  Interestingly, VolA showed a preference for increased temperatures, 
performing optimal conversion of LPC to LCFA at 37˚C.  This optimal activity implies 
that VolA may play a role during infection of the host.  VolA demonstrated a partiality to 
alkaline pH.  It is possible that at an alkaline pH, the active site residues of VolA exist in 
a negatively-charged state, allowing efficient release of the LCFA reaction product 
through electrostatic repulsion (137).   
Our previous work identified several homologs of VolA in other Vibrio species 
(112), including V. alginolyticus, V. vulnificus, V. parahaemolyticus, and V. harveyi.  All 
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were capable of growth using LPC as the sole carbon source while other Vibrios without 
a VolA homolog, such as V. fischeri, lacked this ability.  We identify in this work VolA 
homologs in several other gram-negative organisms – specifically bacteria found in 
marine environments (Table 3.1).  BLAST analysis 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) identified Aeromonas, Alteromonas, and 
Marinobacter species all encode a homolog of VolA.  In lipases, the catalytic serine is 
encoded by a specific sequence: either AGY, where Y is any pyrimidine, or TCN, where 
N is any nucleotide.  Lipases that share the same serine codon may come from a common 
ancestor, as two distinct changes are required to change AGY to TCN and vice versa 
(113, 138).  VolA and its homologs from marine organisms all use a TCN codon to 
encode their catalytic serine, suggesting they have a shared origin.  Notably homologs of 
VolA are absent in terrestrial gram-negatives, indicating VolA may increase the fitness of 
bacteria living in aquatic environments.  A homolog identified in Aeromonas hydrophila 
– encoded by the pla gene (123) – showed the highest sequence identity to V. cholerae 
VolA.  Expression of the Aeromonas homolog was able to complement the Vibrio volA 
mutant restoring lysophopholipase activity and growth on LPC as the sole carbon source 
(Fig. 3.7) suggesting that VolA likely plays a similar role in other aquatic organisms.   
Although the complete role that VolA plays in the life-cycle of V. cholerae 
remains to be seen, there are many ways such an enzyme could confer advantages both in 
the marine and host environments.  A surface-anchored lysophospholipase could have 
potential benefits over a secreted copy.  A secreted enzyme could quickly diffuse away 
from the cell of origin, particularly in aquatic environments, generating valuable lipid 
substrates too distant from the cell to be used.  By anchoring the enzyme to the outer 
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surface of the cell, V. cholerae could produce a local increase in the concentration of free 
fatty acids, preventing any loss of potential substrate.  Additional characterization of 
VolA and its effects on the life-cycle of V. cholerae remain under further study. 
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Chapter 4: Conclusions and Future Directions 
 
Herein we describe novel lipid utilization in the gram-negative pathogen Vibrio 
cholerae.  V. cholerae shows the unique ability to metabolize lysophosphatidylcholine 
(LPC) (Fig. 2.1A).  The data in this work identifies and characterizes the enzyme 
responsible for this ability – VolA – along with demonstrating how VolA is interlinked to 
long-chain fatty acid metabolism.  This ability to metabolize LPC  is intriguing, as it may 
indicate that similar systems for additional lipids exist in V. cholerae and other gram-
negatives. 
Having such systems would permit the bacteria a survival benefit; there is a wide 
variety of lipid substrates available to gram-negatives in their environments.  One of the 
most common lipids encountered by V. cholerae in both the natural environment and its 
human host are the long-chain fatty acids (LCFAs), made of an aliphatic chain variable in 
length with a carboxylic acid head group (Fig 2.1).  The LCFA uptake system is the best-
characterized lipid uptake system identified in Gram-negative bacteria (Fig. 1.4).  The 
enzymes involved in uptake and subsequent metabolism of LCFAs are well-conserved 
across many different organisms (33, 42, 43).   In V. cholerae, this uptake machinery is 
unique; V. cholerae displays a much larger substrate recognition profile than other gram-
negatives.  For example, E. coli recognizes a limited number of LCFAs, while V. 
cholerae can bring much longer and more unsaturated LCFAs into the cell (Table 1.1) 
(57).  
Additionally, while most gram-negatives including E. coli have a single homolog 
of the outer membrane LCFA transporter FadL and acyl-CoA ligase FadD, V. cholerae 
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has three homologs of each [FadL, vc1042, vc1043, vca0862; FadD, vc1985, vc2484, 
vca1110].  
The genome of V. cholerae is separated into two distinct chromosomes (139); the 
primary chromosome is larger and contains a majority of essential cellular functions 
while the second, smaller chromosome encodes a variety of proteins of unknown 
function.  The organization of genes is varied throughout V. cholerae.  Interestingly, V. 
cholerae shows a precedent for the duplication of genes related to nutrient acquisition.  
For example, chitinase, an enzyme that converts chitin found on the surface of colonized 
zooplankton into disaccharide substrates, is duplicated in the V. cholerae chromosome 
(85, 140).  This duplication is even observed with the LCFA uptake machinery.  V. 
cholerae encodes three homologs of the fatty acyl-CoA ligase FadD which are distributed 
throughout both chromosomes [vc1985, vc2484, vca1110].  The distribution of the FadL 
genes in V. cholerae is particularly intriguing; like chitinase and FadD, it is also found 
multiple times in the genome of V. cholerae [vc1042, vc1043, vca0862].  Two of the fadL 
genes, vc1042 and vc1043, exist in an operon together on the first chromosome while the 
other FadL, vca0862, is located on the second chromosome.  This pattern of localization 
is mimicked in many other Vibrio species (Fig. 2.3) (141); given that the second 
chromosome in V. cholerae was probably acquired as a plasmid by an antecedent Vibrio 
species, it remains possible that the additional FadL homologs were acquired and 
maintained due to their contribution to survival.  The duplication of FadL in the operon 
on the primary chromosome is very remarkable because unlike FadD, the 
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Figure 4.1 LCFA uptake is maintained in fadL and fadD mutants of V. cholerae  
TLC chromatography results of LCFA uptake assays in various fadL and fadD transposon 
mutants of V. cholerae.  A) Uptake of C22:6 LCFA.  Disruption of individual fadL or 
fadD genes had no effect on the uptake of C22:6 fatty acid. Red asterisks denote shifts 
that confirm uptake.  B) Uptake of C20:5 LCFA.  These TLC experiments are 
representative of all LCFA species tested.  Similar results were obtained with C20:4 and 
C18:3 fatty acids. 
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genes are transcribed together in an operon by themselves. Mutation of a single homolog 
of FadL has no deleterious effect on the LCFA uptake ability of V. cholerae (Fig 4.1).  
Uptake assays using various LCFA substrates suggest that regardless of which FadL 
homolog is mutated the complete substrate profile is maintained.  While it remains 
possible that each FadL is dedicated to the uptake of particular LCFA substrates, this data 
indicates that the homologs are redundant.  Duplication of nutrient uptake machinery like 
FadL could facilitate survival in the nutrient-poor environments with which V. cholerae 
is commonly associated, such as the ocean sediment or the surface of marine shellfish.   
The operation of FadL has been described in multiple studies (33, 39, 40, 142) 
(Fig. 4.2).  Initial recognition of LCFAs by FadL occurs at the so-called “low-affinity” 
binding pocket (142) (Fig 4.2).  A large loop extends from the surface of FadL into the 
extracellular milieu, forming a solvent-accessible hydrophobic groove (Fig 4.2B); this 
groove serves to bind the LCFA in the environment prior to entry into the core of the 
protein.  Structural predictions of the V. cholerae homologs reveal an intriguing feature: a 
significant truncation of this low-affinity binding pocket.  The V. cholerae FadL 
predictions, (Fig. 4.3) modeled off of the existing E. coli crystal structure, largely 
maintain the traditional β-barrel backbone.  Also present are the other distinctive  
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Figure 4.2 Crystal structure of E. coli FadL 
A) Total structure of E. coli FadL protein (PDB 1T1L).  FadL is a 14-stranded β-barrel.  
It has a long extracellular loop that serves as an initial low-affinity binding site for 
LCFAs (red).  The core of the barrel is plugged by the structured N-terminal helix 
(green).  A disruption in the hydrogen bonding on the side of the barrel (blue) serves as 
the exit point for LCFA substrates.  B) The low-affinity binding cleft of E. coli FadL.  
Hydrophobic residues are colored blue.  The extracellular loop contains a hydrophobic 
groove that serves to bind LCFA substrates from the medium (red asterisk).  Surface 
representation has been included to aid in visualization of the hydrophobic groove. 
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Figure 4.3 Predicted Structure of V. cholerae FadL homologs 
Structural predictions were generated via 1-to-1 threading using E. coli FadL as a 
template.   Overall structures showed little deviation from E. coli FadL with exception for 
the low-affinity groove on the extracellular loop.  A) Structure of VcA0862.  B) Surface 
representation of the hydrophobic groove of VcA0862.  Putative LCFA binding clefts in 
surface maps are marked with a red asterisk.  Hydrophobic residues lining the cleft are 
colored in blue.  C) Structure of Vc1042.  D) Surface representation of the groove of 
Vc1042.  The “top” of Vc1042 shows a much more open binding surface.  The groove 
transverses the barrel of the protein.  E) Structure of Vc1043.  F) Surface representation 
of Vc1043.  Hydrophobic contacts line the upper portion of the barrel providing an 
extensive binding surface for LCFA substrates. 
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structures of FadL, namely an N-terminal loop that acts as a central plug and a disruption 
of the hydrogen bonding network in the lateral side of the barrel where the lipid is 
ejected.  The most significant deviation from the E. coli structure is the loss of alpha-
helices from the extracellular loop; the hydrophobic groove is preserved, but with a much 
larger surface available for binding of LCFA substrates (Fig. 4.3B, D, and F).  This 
critical change may be responsible for the expanded substrate recognition observed in V. 
cholerae; it is possible that by truncating this extracellular loop and enlarging the 
hydrophobic binding groove, the V. cholerae FadL proteins permit the capture of much 
longer substrates.  Current investigations into the characterization of the V. cholerae 
FadL homologs are ongoing. 
The least understood step of LCFA transport is the passage of substrates from the 
point of ejection from FadL to the point of ligation to CoA via FadD.  How the LCFA is 
transported through the periplasmic space and inner membrane is currently unknown.  
There are several options for how this process might take place.  The first and most 
straightforward mechanism for transport is simple diffusion; studies on LCFA transport 
in mammalian cells have suggested that free fatty acids are able to adsorb and desorb 
from phospholipid membranes (143, 144).  In the case of LCFA transport by gram-
negatives, the lipids are initially expelled by FadL into the inter-membrane space 
between the outer and inner leaflets of the outer membrane, most likely sorting into the 
inner leaflet.  At this point, the LCFA could desorb from the outer membrane, pass 
through the periplasmic space, and adsorb to the inner membrane.  It has been 
hypothesized that acidification of the periplasm via diffusion of protons across the inner 
membrane may cause the protonation of free LCFAs (145);  this protonation event would 
 75 
allow the LCFA to partition into the inner membrane.  The lipid could then flip to the 
inner leaflet, where FadD could extract it from the membrane (144).  While this process 
is simple and observed in other systems, including rat adipocytes (146), it allows the 
possibility that once transported into the periplasm, LCFAs could potentially re-associate 
with the outer membrane, flip to the surface and desorb into the environment.  Some 
mechanism to maintain directionality of LCFA transport thus must exist; it is possible 
that a devoted transporter is present but remains undiscovered.   
Other systems for the transport of lipids across the periplasmic space of gram-
negatives have been previously described (147, 148).  Maintenance of the cell envelope 
relies on the ability to traffic phospholipids between the inner and outer membranes; the 
mechanism for anterograde trafficking is unknown, but the Mla ABC transporter has 
been identified as a retrograde transporter, bringing phospholipids from the outer to the 
inner membrane (147).  This system utilizes a periplasmic shuttle, MlaC, to receive 
phospholipids from the outer membrane-associated MlaA and bring them to the MlaDEF 
complex.  A similar method is used for the delivery of nascent lipopolysaccharide to the 
gram-negative outer membrane (148).  Here, the ABC transporter MsbA flips the 
lipopolysaccharide to the periplasmic face of the inner membrane and a suite of Lpt 
proteins transport it to the outer membrane.  Specifically, the periplasmic shuttle protein 
LptA (41) binds the LPS molecule and hands it directly to the outer membrane receiving 
protein LptD.  Interestingly, LptA does not travel through the periplasm; it instead 
oligomerizes to form a bridge between the inner and outer membranes (149, 150).  There 
is also the periplasmic shuttle involved in transporting mature lipoproteins, LolA, which 
binds protein substrates via their N-terminal lipid domain (151).  LCFAs may use a 
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similar type of transporter to the MlaC, LptA, or LolA proteins, although determination 
of such a system continues to be difficult due to potential redundant mechanisms.  There 
is the possibility that the duty of transporting LCFAs might be shared with these existing 
systems.  Discovery of this mechanism would be a novel and important contribution to 
the study of fatty acid transport. 
Our work elucidates how a lipid processing enzyme (VolA) can interface with the 
existing LCFA transport machinery.  Many lipid substrates are available to V. cholerae 
during its life cycle.  After a previous study (57) from our laboratory determined that V. 
cholerae could utilize a variety of LCFAs not known to be accessible to other gram-
negatives, we hypothesized that V. cholerae could also use alternative lipids that it 
encounters.  Experimentation revealed that V. cholerae can utilize 
lysophosphatidylcholine (LPC) as a sole source of carbon, an ability not shared with 
other gram-negatives, including E. coli.  This phenotype was shared with a variety of 
Vibrio species, with the notable exception of V. fischeri.  Analysis of the V. cholerae 
genome showed an annotated lipase, VolA, in close proximity to one of the FadL 
homologs.  This pairing was found to be maintained in all strains capable of growth on 
LPC as the sole carbon source.  Further data determined that expression and proper 
localization of VolA is absolutely essential for the LPC utilization phenotype. 
 One of the more interesting attributes of VolA is its expression as a lipoprotein.  
Mass spectrometry data (Fig. 3.3) revealed that VolA is modified with the canonical N-
terminal lipidation found in bacteria.  Gram-negative precursor lipoproteins are expressed 
with an N-terminal localization signal in the cytosol and transported to the periplasm via 
the Sec translocation machinery.  Here they are modified into their mature form through 
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the action of three well-conserved enzymes (127): the prolipoprotein diacylglycerol 
transferase Lgt, which ligates a diacylglycerol moiety to a Cys residue located 
immediately downstream of the N-terminal Sec-dependent signal peptide; the signal 
peptidase LspA, which cleaves the signal peptide exposing the modified Cys residue; and 
the apolipoprotein transacylase Lnt, which adds an acyl chain to the already-modified N-
terminus.  These lipid modifications function to anchor the mature protein into the 
membrane.   
Mature lipoproteins can be anchored into the inner or outer membrane based on a 
sorting signal (77) (Fig. 4.4).   An ABC transporter, LolCDE, recognizes lipoproteins 
based on the identity of the amino acid in the so-called “+2” position that follows the 
modified N-terminal Cys residue.  An aspartate in this position acts as an avoidance 
signal, leaving the protein embedded in the inner membrane.  However if this residue is 
not an aspartate, the LolCDE complex delivers the lipoprotein to the periplasmic shuttle 
LolA. Lipoproteins are captured via their N-terminal lipidation and handed to the outer 
membrane-associated LolB, which incorporates the lipoprotein into the outer membrane.  
With VolA and its homologs in other organisms, this outer membrane signal is present, 
forcing VolA through the Lol sorting pathway. 
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Figure 4.4 Lipoprotein sorting in Gram-negative bacteria 
Lipoproteins are generated in the cytoplasm and embedded in the periplasmic face of the 
inner membrane after transport via the Sec translocon.  Depending on the identity of the 
amino acid in the +2 position following signal peptide cleavage, the lipoprotein is 
recognized (if the residue is not an aspartate) or avoided (if the residue is an aspartate) by 
the LolCDE ABC transporter.  LolCE binds the lipoprotein and delivers it to the 
periplasmic shuttle LolA.  LolA recognizes and binds the outer membrane lipoprotein 
LolB, which receives the nascent lipoprotein and embeds it in the periplasmic face of the 
outer membrane.  The last step, flipping to the outer surface of the cell, is an 
uncharacterized process. 
 
 
 
+2 Asp 
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Interestingly, VolA is unique in regards to its localization; unlike most 
lipoproteins, VolA is anchored on the surface of the cell.  A surface-anchored 
lysophospholipase could have potential benefits over a secreted copy.  In the ocean a 
secreted enzyme could quickly diffuse away from the cell of origin, generating valuable 
lipid substrates too distant from the cell to be used.  By anchoring the enzyme to the outer 
surface of the cell, V. cholerae could produce a local increase in the concentration of free 
fatty acids, preventing any loss of potential substrate.  Additionally, the fact that VolA is  
co-expressed with the LCFA transporter FadL indicates that these proteins might interact 
to ensure liberated LCFAs are not lost.  To date, few surface-exposed lipoproteins have 
been identified in gram-negative organisms (82, 107–110).  The mechanism for 
deposition of lipoproteins to the cell surface is currently uncharacterized.  When 
analyzed, no commonality can be found between the surface-exposed lipoproteins, either 
in function or sequence.  No specific signal has been identified for targeting a specific 
lipoprotein to the surface, but this does not mean a signal does not exist.  Lipoprotein 
surface localization signals do exist in other bacterial systems; the spirochete Borrelia 
burgdorferi uses a unique method of sorting lipoproteins to the outer surface of the cell.  
Despite having a cell envelope very similar to that of gram-negative organisms, B. 
burgdorferi does not use the same lipoprotein sorting rules.  Instead, B. burgdorferi 
recognizes a specific signal in the N-terminal lipid tether that anchors the protein to the 
membrane.  A conserved penta-peptide sequence in the N-terminal tether directs sorting 
to the surface via an unknown mechanism; it has been determined that presence of this 
sequence within the tether is important for proper localization, rather than specific 
positioning of the sequence (like the general lipoprotein +2 sorting rules) (152, 153).  In 
 80 
V. cholerae and other gram-negatives, it is unclear as to whether a specific protein exists 
in the outer membrane to flip lipoproteins to the surface,  although due to being 
energetically unfavorable it is unlikely that proteins would freely flip across the 
membrane.  Regardless of how this process occurs, data from this work demonstrates that 
the machinery for ensuring proper localization of VolA to the surface of the cell also 
exists in E. coli (Fig. 2.5).  Also, given that mislocalization of VolA to the inner 
membrane via mutation of the +2 residue to Asp completely abrogates both utilization of 
LPC and surface localization, it is clear that this step occurs after transport by LolA and 
LolB to the outer membrane.  Methods to aid in the elucidation of this mechanism are 
under development. 
Due to the dependence of the LPC utilization phenotype on the expression of 
VolA, and the annotation of VolA as a lipase, we initially hypothesized that the protein 
was somehow involved in cleaving the LPC substrate.  This is supported by the 
incorporation of fatty acids derived from LPC into the phospholipids of strains expressing 
VolA (Fig. 2.7).  Indeed, our initial experiments in vitro using purified VolA show 
release of LCFA from a radiolabeled LPC substrate (Fig. 3.2).  The co-expression of 
VolA with a homolog of FadL in V. cholerae indicates that the release of LCFA from 
LPC via the action of VolA may be coupled its subsequent uptake.  This is unique; LCFA 
transport in gram-negatives is well characterized, but to date no other proteins have been 
identified that feed directly into this system.  It is unknown if VolA and FadL directly 
interact; initial coimmunoprecipitation experiments do not show binding between VolA 
and its co-expressed FadL (VcA0862).  Additionally, a vca0862 mutant does not show 
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any loss in the ability to use LPC as a carbon source, which suggests that any of the FadL 
homologs can serve to bring in LPC-derived LCFA.   
VolA is the first known instance of a surface-anchored lipoprotein 
lysophospholipase.  The activity is similar to many existing phospholipases.  
Interestingly, in VolA and its homologs, a conserved serine was identified within a 
previously established Gly-Xaa-Ser-Xaa-Gly motif (113).  This motif is found in many 
phospholipases.  One of the most common mechanisms of phospholipases is the use of 
the central serine within this motif in an Asp-His-Ser triad (133).  Mutation of this serine 
in VolA renders the enzyme non-functional (Fig. 3.6).  In addition to the Gly-Xaa-Ser-
Xaa-Gly motif, VolA contains other properties commonly associated with lipases.  
Phospholipases stabilize their reaction intermediates utilizing a structure called an 
oxyanion hole (154).  In most phospholipases this oxyanion hole is marked by either a 
Gly-Gly-Gly-Xaa or Gly-Xaa motif (135); those lipases that contain the Gly-Gly-Gly-
Xaa motif are known act on short-chain lipid substrates.  This motif is notably absent in 
VolA, which correlates with its activity on LCFAs. Furthermore, given that VolA 
liberates the LCFA moiety from LPC, it is likely that the enzyme is acting as an “A” 
phospholipase, acting directly on the ester bond between the fatty acid chain and the 
glycerol backbone (155). 
In addition to the sequence analysis of VolA, our work also establishes its 
enzymatic parameters.  We demonstrate that VolA is active on linear scale with time, 
indicative of an enzyme,  and show that VolA has dependences on both temperature and 
pH.  VolA displays an enzymatic optima at 37˚C.  This may indicate that VolA evolved 
to function primarily within its human host.  Lipid remodeling can contribute to the 
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survival of V. cholerae within the intestine; generation of additional LCFA substrates 
from available lipids in the host could confer an advantage during infection.  The enzyme 
also demonstrates maximum activity at pH 8.   This could potentially have an overall 
effect on the ability of VolA to rapidly convert LPC substrates to LCFAs.  Many lipases 
utilize an “electrostatic catapult”: positive charges within the active site to aid in 
expelling the negatively-charged product (137).  This allows the enzyme to turn 
substrates over more rapidly.  The dependence of VolA on increased pH could be 
indicative that this mechanism is important for its activity.  
 Phospholipases are varied in their required conditions for enzymatic activity.  
Often they will require a specific temperature and pH; many also have requirements for 
co-factors such as divalent cations (118, 119, 156).  VolA does not display any 
dependence on common metal co-factors; addition of either metal chelators or 
supplemental divalent cations had no overall effect on the conversion of LPC to LCFA 
(Fig. 3.4).  The lack of requirement on such co-factors could be based on the availability 
of divalent cations in different niches of V. cholerae.  In the aquatic environment, cations 
such as calcium or magnesium are present in ranges from low micromolar concentrations 
in the ocean to nanomolar concentrations in estuary and freshwater environments.  
Generally, phospholipases that show dependence on metal ions require increasingly high 
concentrations, often trending into millimolar quantities (157).  VolA thus may have 
evolved to function in the absence of such ions in the aquatic environment prior to 
adaptation to its human host. 
 VolA is unusual in its distribution among gram-negative species.  Bioinformatic 
analysis identified VolA in a variety of Vibrio species, all of which are able to utilize 
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LPC.  A more interesting discovery was the conservation of VolA in other aquatic 
organisms.  VolA is shared among several members of the gammaproteobacteria, 
including Aeromonas hydrophila, among others.  The conservation of VolA in aquatics is 
indicative that the enzyme may have been acquired by an ancient ancestor of these 
organisms.  This is supported by the fact that VolA is completely absent from any 
terrestrial gram-negative, including E. coli and Pseudomonas aeruginosa.  Also 
supporting this idea is the analysis of the codon usage of these homologs.  The catalytic 
serine in phospholipases is encoded by one of two codons, AGX or TCX.  Because two 
separate nucleotide mutations are required to alter one codon to other, previous studies 
have suggested that lipases which share a particular codon arose from a common 
predecessor (113, 138).  VolA homologs all utilize a TCN codon for their catalytic serine.  
Because of the shared features of the homologs and unique pattern of expression, it is 
possible that VolA was originally acquired by an antecedent and maintained in response 
to the low nutrient availability of aquatic environment.  
Despite most likely being acquired in response to the aquatic environment, VolA 
shows enzymatic parameters that indicate it functions during infection of the host, 
supporting the idea that  VolA plays a role in the virulence of V. cholerae.  It has 
previously been shown that arachidonic acid, found in the human intestinal epithelium 
(158), is metabolized into prostaglandins, potent inflammatory signal molecules (159).  
Working in concert with a host-derived phospholipase (160, 161), VolA could release 
arachidonic acid to be converted into prostaglandin.  Interestingly, Prostaglandin E has 
previously been shown to exacerbate the secretory processes leading to water loss that 
occurs when the host is infected with V. cholerae (162).  VolA could thus aid in 
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increasing the diarrhea-induced dissemination of V. cholerae by generating pro-
inflammatory molecules; inflammatory responses in the gut could also cause release of 
epithelial membrane lipids, providing additional substrates for VolA leading to further 
inflammation (163).  Additional characterization of VolA and its effects on the life-cycle 
of V. cholerae remain under further study. 
The complete role VolA plays in the life-cycle of V. cholerae remains to be fully 
seen; there are many ways such an enzyme could confer advantages both in the marine 
and host environments.  One of the most important contributions of VolA is providing V. 
cholerae access to a larger array of lipid nutrients.  By connecting the release of LCFAs 
from LPC directly to the LCFA uptake machinery, V. cholerae can tap into previously 
unused resources.  Other proteins might also interface with this system; V. cholerae was 
previously shown to express a lecithinase (97), which could free LPC substrates for 
VolA.  One important, unanswered problem is the fate of the released head group.  As 
VolA releases LCFA from LPC, a molecule of glycerophosphocholine is also generated 
(Fig. 3.1).  Glycerophosphocholine is a relatively small molecule, and like other 
glycerophosphodiesters can likely pass through the outer membrane via a porin.  Once 
inside the cell, action of periplasmic glycerophosphodiester phosphodiesterase (164) 
could theoretically convert glycerophosphocholine into glycerol-3-phosphate, which 
could then be metabolized by the cell.  As this could be an important source of energy for 
the cell, it is unlikely that the released head group is lost from the cell. 
  This work characterizes the novel instance of a surface-exposed lipoprotein 
lysophospholipase in a gram-negative organism.  Lipids play an important role for V. 
cholerae both as a source of nutrition and as a way to remodel its membrane architecture.  
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Further elucidation of how VolA is transported to the surface of the cell, as well as the 
exact relationship between VolA and the LCFA uptake machinery, are important gaps in 
our understanding of how this enzyme functions in V. cholerae.  Illumination of these 
gaps will greatly contribute to the general understanding of lipoprotein biology and lipid 
utilization in gram-negative organisms.  
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Chapter 5: Experimental Procedures 
 
5.1 MATERIALS AND METHODS 
5.1.1 Bacterial strains and growth conditions 
The bacterial strains, plasmids, and oligonucleotides used in this study are listed in 
Section 5.2.   Bacterial growth experiments were performed in modified M9 minimal 
medium containing M9 minimal salts and supplemented with 1.7 mM MgSO4, 0.117 mM 
CaCl2, 0.03 mM FeSO4 and a carbon source as indicated (69, 165); strains requiring 
additional salt (V. parahaemolyticus) were grown in the same medium supplemented with 
3% NaCl.  All strains were grown at 37˚ C, except for V. fischeri which was grown at 
22˚C.   Medium was added to 96-well F96 microtiter plates (Nunc) to a final volume of 
200 µL, and culture was added to an OD600 of 0.05.  Glucose was supplemented at 0.2% 
(w/v) and LCFA or LPC C16:0 were supplemented at 2 mM, respectively.  Brij-56 was 
added to a final concentration of 6mM for lipid stability in solution.  For V. fischeri, an 
artificial seawater-based minimal media  was used (166).  For growth curves, OD600 
readings were taken every half hour using a Synergy H1 Hybrid Multi-Mode Microplate 
Reader (BioTek).  For single read experiments, an OD600 reading was taken after 24 
hours.  For experiments not involving growth curves, bacterial strains were generally 
grown at 37˚C on LB broth.   
5.1.2 Isolation of radiolabeled phospholipids 
Cultures were labeled with 2.5µCi/mL 32Pi (Perkin Elmer) and grown to an OD600 of 
~1.0.   Cells were harvested at 4,000 g for ~15 min.  Lipid extraction was performed 
using the previously established method of Bligh and Dyer (167).  For thin-layer 
chromatography analysis, isolated phospholipids were spotted onto Silica Gel TLC plates 
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(Fisher Scientific) at 10,000 cpm/lane.  Extracted phospholipids were separated via a 
chloroform : methanol : acetic acid (65:25:10 v/v).   TLC plates were exposed for ~20 
hours to a phosphor screen (Kodak) and analyzed via a Personal Molecular Imager with 
Quantity One analysis software (Bio-Rad).   
5.1.3 RNA Extraction and Quantitative RT-PCR  
Total RNA was extracted using the SV Total RNA Isolation Kit (Promega) from cultures 
grown in minimal media to a final OD600 of 0.6.  RNA was treated with RQ1 RNAse-free 
DNAse (Promega) to eliminate genomic DNA contamination.  cDNA template was 
generated using the High-Capacity cDNA Reverse Transcriptase Kit (Applied 
Biosystems).  To verify the transcription of specific genes, a standard PCR was 
performed; vca0862 was amplified from cDNA using primers 62F and 62R; vca0863 was 
amplified using primers 63F and 63R while the region spanning the non-coding sequence 
between vca0862 and vca0863 was amplified with primers 62bF and 63bR (Table 5.2).  
The PCR products were visualized by electrophoresis on 1% agarose gel.  For 
quantitative PCR, the 2X SYBR Green PCR Master Mix (AB Applied Biosystems) was 
used.  Data analysis was performed using ABI 7900HT Fast Real Time PCR System and 
the Software Sequence Detection Systems (SDS) version 2.4 (AB Applied Biosystems).  
The relative expression ratio of the target transcript was calculated in comparison to the 
gyrA transcript as the reference gene following the Pfaffl method (Pfaffl, 2001) using 
primers gyrAF and gyrAR. gyrA was selected as the reference gene due to its essential 
nature and because its transcript levels remained unchanged under the experimental 
conditions. 
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5.1.4 Generation of expression plasmids and site-directed mutagenesis of VolA 
The volA (vca0863) complementation construct was generated in the low-copy-number 
plasmid pWSK29.  Oligonucleotides for and vectors used for plasmid construction are 
listed in Table 5.2.  Initially, volA was amplified from C6706 genomic DNA using 
primers 0863NF and 0863BR, or 0863HR which incorporates a C-terminal 6x histidine 
tag.  The vector was digested with BamHI and NdeI and ligated into high-copy-plasmid 
pET21a.   The insert was digested out of pET21a using XbaI and XhoI and subsequently 
ligated into pWSK29.  Other genes were inserted into pWSK29 in a similar manner.  The 
volA G20D mutant was generated using primers G20DF and G20DR; ampC was 
amplified using primers BLF and BLR; ompT was amplified using primers OmptF and 
OmptR.  The active site serine mutants were generated by using site-directed mutagenesis  
primers 551AF/AR and 551TF/R with the wild-type volA expression plasmid as a 
template.  The A. hydrophila pla gene was cloned into pWSK29 as described above. 
5.1.5 Generation of VcA0863-specific polyclonal antibody 
VcA0863-specific polyclonal antibody was generated by the Genscript corporation.  
Briefly, a fifteen amino acid peptide (CGERSLDSTRSANSD) predicted to be solvent-
exposed was selected from the primary sequence of VcA0863 and used to generate 
VcA0863-specific antibody from rabbits.  
5.1.6 Whole cell labeling with NHS-LC-LC biotin 
Labeling of the cell surface with NHS-LC-LC biotin was performed as previously 
described (82).  Proteins were purified via affinity chromatography using HisPur Cobalt 
Resin (Pierce).  Cells were lysed in a buffer of 10 mM Tris-HCl, 250 mM NaCl, 2.5% 
 89 
Triton X-100 and 20 mM imidazole; clarified cell extract was incubated on the cobalt 
resin and purified protein was eluted using 500 mM imidazole.   Western blot analysis 
was carried out as described above using a 1:600000 dilution of a 1.25 mg/mL solution of 
streptavidin-conjugated horseradish peroxidase (Pierce).  
 
5.1.7 Immunogold electron microscopy 
Strains of wild-type, vca0863::TnFGL3, and pVcA0863-carrying V. cholerae were grown 
to mid-log phase in 5 mL of LB medium.  1.5 mL of mid-log culture was harvested at 2.8 
x 1000 rpm for 5 min and re-suspended in 500 µL of PBS.  Cells were pelleted and re-
suspended in a final volume of 100 µL PBS.  Bacteria were adsorbed to formvar/carbon 
coated nickel grids and blocked for 20 min in 0.3% skimmed milk in PBS (M-PBS).  The 
grids were then incubated with a 1:50 dilution of the anti-VcA0863 antibody for 30 min, 
followed by three 2-min washes in PBS.  Washed grids were incubated with a 1:20 
dilution of gold-conjugated goat anti-rabbit IgG in M-PBS.  After a 30 min incubation, 
grids were washed three times for 2 min in PBS, followed by three 2-min washes in 
sterile water.  Grids were visualized in a FEI Tecnai Transmission Electron 
Microscope at 80 KeV. 
 
5.1.8 Preparation of cell-free extracts and washed membrane 
200 mL of culture was induced with 0.5 mM IPTG upon inoculation and grown at 37˚C 
to an OD600nm of ~1.0 and harvested via centrifugation at 10,000 g for 10 min.  All 
following steps were performed at 4˚C.   Initially cultures were washed in ~20 mL 
phosphate buffered saline (pH 7.4) and resuspended in ~15mL of 50mM HEPES (pH 7.5) 
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following by lysis via sonication.   Cell lysates were clarified by centrifugation at 10,000 
g for 15 min.  Washed membranes were prepared by centrifugation at 100,000 g for 1 
hour in a Beckman ultracentrifuge.  Membrane pellets were resuspended in ~8 mL of 50 
mM HEPES (pH 7.5) and harvested by a second round of ultra-centrifugation.  The 
double-washed membrane pellet was then resuspended in a final volume of 500 µL50 
mM HEPES (pH 7.5).  Protein concentration was established by BCA assay using bovine 
serum albumin as a standard.  Purified cell-free lysate and membranes were stored at -
20˚C.    
 
5.1.9 Expression and purification of V. cholerae VolA 
E. coli strain BL21 (DE3) containing pVolA-8H  (Table 5.2) was grown overnight in 50 
mL of LB broth at 37˚C.  This overnight was used to inoculate a 1 L culture of LB broth 
with 100 µg mL-1 ampicillin and induced with 500 µM of IPTG.  The culture was 
harvested at an OD600nm of ~1.0 via centrifugation at 10 000 x g for 10 min.  The 
resulting cell pellet was washed in 40 mL 50 mM HEPES, pH 7.5.  The pellet was then 
resuspended in ~20 mL of Buffer A (250 mM NaCl, 20 mM imidazole, 10 mM HEPES 
pH 7.5), containing either 2% Triton X-100 [for enzymatic assays] or 7 M urea [for mass 
spectrometry] and lysed via sonication in a Branson Sonifier 250.  Cell debris was 
removed from the sample via centrifugation at 10,000 x g for 20 min.  A GE Life 
Sciences AKTA FPLC was used to load the sample on a 1 mL His-Trap FF column 
charged with Ni-Sepharose 6 Fast Flow and the column was washed with 20 column 
volumes of Buffer A.  Protein was purified via a 30 mL continuous gradient from 100% 
Buffer A to 50% Buffer B (250 mM NaCl, 500 mM imidazole, 10 mM HEPES pH 7.5, 
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containing either 2% Triton X-100 or 7 M urea), applied at 0.5 mL min-1.  The protein 
eluted at ~80 mM imidazole.  SDS-PAGE was used to confirm which fractions contained 
VolA, which were pooled and concentrated in a 15 mL Amicon Ultra concentrator 
(Millipore).  Concentrated VolA was further purified using the AKTA FPLC and a 24 
mL Superdex 200 gel filtration column equilibrated with Buffer C (150 mM NaCl, 10 
mM HEPES pH 7.5, 2% Triton X-100 or 7M urea) at 1 mL min-1.  Purified protein was 
collected in 500 µL fractions and VolA purity established via SDS-PAGE.  The 
molecular weight determination of VolA was performed via mass spectrometry by the 
ICMB Protein and Metabolite Analysis Facility using a 4000 QTRAP instrument (AB 
Sciex).   
 
5.1.10 Assay of VolA lysophospholipase activity 
 Lysophospholipase activity was assayed under in a 22.5 µL reaction containing 50 mM  
HEPES pH 7.5, 0.4% Triton X-100 and 20 µM C16:0 L-1-[palmitoyl-1-14 146 C] 
(111,000 cpm nmol-1) (PerkinElmer).  For membrane assays, protein was added at 0.1 mg 
mL-1 as the enzyme source; for pure protein assays, enzyme was added at a 
concentration of 0.002  
mg mL-1 (24 nM VolA).   In assays supplemented with metal ions or metal ion chelators; 
CaCl2, MgCl2, EDTA, or EGTA were added to a final concentration of 10 mM.  
Reactions were incubated at 30ÛC for 15 min and terminated by spotting 10 µL portions 
on silica gel 60 TLC plates.  The products of the reaction were separated using a 
chloroform, methanol, 28% ammonia hydroxide (65:25:8, v/v) solvent system.  
Temperature dependence was assayed by using standard enzymatic conditions and 
 92 
incubating the reaction mixture at 4 to 42˚C.  Dependence on pH was established via a 
step-wise gradient from pH 4 to 9 using a modified tri-buffer system (168), with 100 mM 
sodium acetate, 50 mM 2-(Bis-2(hydroxyethyl)imino-2-(hydroxmethyl)-1,3-propanediol, 
and 50 mM Tris.  TLC plates were analyzed and quantitative densitometry performed via 
Quantity One software and a Personal Molecular Imager phosphoimager (Bio-Rad). 
5.1.11 Structural prediction of Vibrio FadL homologs 
Structural predictions of FadL homologs from V. cholerae were obtained using the Phyre 
2 prediction software.  Briefly, amino acid sequences for V. cholerae proteins were 
mapped against the existing crystal structure of E. coli FadL (PDB 1T1L).  Structural 
analysis and comparison to the E. coli structure were performed via use of Pymol. 
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5.2 BACTERIAL STRAINS AND OLIGONUCLEOTIDES 
Table 5.1 Bacterial strains and plasmids used in Chapter 2 
 
Strain, plasmid 
 
 
Description 
 
Source or 
Reference 
 
Bacterial strains 
 
Escherichia coli 
  
BW25113 
 
Wild-type K12, F-, λ- (169) 
BW25113, vca0863+ 
 
BW25113 pVcA0863, AmpR Present Work 
BW25113, ∆fadL::nptII 
 
BW25113, ∆fadL, KanR (169) 
BW25113, ∆fadL::nptII,     
   vcA0863+ 
BW25113, ∆fadL, pVcA0863,  
   AmpR, KanR 
 
Present Work 
Vibrio cholerae 
 
  
C6706 
 
O1 El Tor biotype, lacZ- (170) 
C6706 vca0863 C6706 containing transposon  
   insertion in vca0863 
 
(170) 
vca0863, vca0863+ C6706, pVcA0863, AmpR Present Work 
 
C6706, vca0863-His+ C6706, pVcA0863-His, AmpR Present Work 
 
C6706, vca0863-G20D+ C6706,pVcA0863-G20D, 
AmpR 
Present Work 
 
C6706, vca0863-G20D-   
His+ 
C6706, pVcA0863-G20D-His,  
   AmpR 
 
Present Work 
C6706, ampC-His+ C6706, pBL-His, AmpR Present Work 
 
C6706, vc1854-His+ C6706, pOmpT-His, AmpR Present Work 
   
Vibrio alginolyticus Z096 Clinical isolate ETSU*, Clinical 
Laboratory 
   
Vibrio fischeri ES114 Wild-type (171) 
   
Vibrio harveyi BAA-1116 Wild-type ATCC 
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Table 5.1 continued   
Vibrio parahaemolyticus Clinical isolate East Tennessee 
State University, 
Clinical 
Laboratory 
   
Vibrio vulnificus CAP-D-08 Clinical isolate ETSU, Clinical 
Laboratory 
 
 
Plasmids 
  
pET21a High-copy number cloning  
vector, AmpR 
Novagen 
   
pWSK29 Low-copy number cloning  
   vector, AmpR 
(172) 
   
pET0863 pET21a containing vca0863 Present work 
   
pVcA0863 pWSK29 containing vca0863 Present work 
   
pVcA0863-G20D pWSK29 containing vca0863    
   with G20D mutation 
Present work 
   
pVcA0863-His pWSK29 containing vca0863,  
   C-terminal 6x histidine tag 
Present work 
   
pOmpT-His pWSK29 containing vc1854,    
   terminal 6x histidine tag 
Present work 
   
pVcA0863-G20D-His pWSK29 containing vca0863,  
   G20D mutation, C-terminal  
   6x histidine tag 
Present work 
   
pBL-His pWSK29 containing ampC,  
   C-terminal 6x histidine tag 
Present work 
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Table 5.2 Oligonucleotides used in Chapter 2 
   Primer Name    Sequence (5’-3’) 
 
0863NF 
 
GCGCGCCATATGAAACAGGTTATT
AAGCTC 
 0863BR GCGCGCGGATCCTTACTTCAAGAC
AGAGTT 
 
0863HR GCGCGCGGATCCTTAGTGGTGGTG
GTGGTGGTGCTTCAAGACAGAGTT 
 
62F GAATTTCGATGATGGCGAGT 
 
62R GCTGGAAGTGGCAGTGAGTT  
 
63F TGTCACCACTGCCAAAGAAA  
 
63R GGCCAAGTAGGTGAGGTTGA  
 
62bF TTGCGTTAGTACAGAGCCGT  
 
63bR GGCCAGCCATCCACTTGTCC  
 
G20DF CTCTGGTTAGCCGGTTGCGACGAT
GAGACCAATAGTTCAG  
 
G20DR CTGAACTATTGGTCTCATCGTCGCA
ACCGGCTAACCAGAG  
 
BLF GCGCGCCATATGTTCAAAACGACG
CTCTGC  
 
BLR GCGCGCGGATCCTTAGTGGTGGTG
GTGGTGGTGCTGTAGAGCGTTAAG 
  
OmptF GCGCGCCATATGGAAAACCACCTT
C 
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Table 5.2 continued 
OmptR 
 
GCGCGCGGATCCTTAGTGGTGGTG
GTGGTGGTGCCAGTAGATACGAGC  
  
gyrAF 
 
 
 
CCGATAAGAACGGCAAAGAA  
 
 
gyrAR 
 
GTGCACTGATCCCTTCGACT  
 
Table 5.3 Bacterial Strains and plasmids used in Chapter 3 
Strain or plasmid  Genotype or description  Source or Reference 
 
Escherichia coli 
 
BL21 Star (DE3)  Wild-type B, FompT hsdSB (rB- mB-)  
gal dcm rne131 (DE3)         Invitrogen 
 
      BL21, volA+  BL21 Star (DE3), pVolA-8H, AmpR  Present Work 
 
Vibrio cholerae 
C6706   O1 El Tor biotype, lacZ-           (170) 
 
C6706 ∆volA   C6706 containing transposon insertion  
in volA      (170) 
 
∆volA, pWSK29  C6706, pWSK29, AmpR   Present work 
 
∆volA, volA+  C6706, pVolA, AmpR    (112) 
 
∆volA, volA+  C6706, pVolA-S551A, AmpR  Present work 
 
∆volA, volA+  C6706, pVolA-S551T, AmpR   Present work 
 
∆volA, pla+   C6706, pPLA, AmpR    Present work 
 
Aeromonas hydrophila ZY01 Wild-type     Payne Lab 
 
Plasmids 
 
pWSK29   Low-copy number cloning vector, AmpR (172) 
 
pVolA   pWSK29 containing volA,   (112) 
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Table 5.3 continued 
pVolA-8H   pWSK29 containing volA ,     
    C-terminal 8x histidine tag   Present work 
 
pVolA-S551A  pWSK29 containing volA, S551A mutation Present work 
 
pVolA-S551T  pWSK29 containing volA, S551T mutation Present work 
 
pPLA   pWSK29 containing pla from A. hydrophila Present work 
 
 
 
Table 5.4 Oligonucleotides used in Chapter 3 
Primer Name  Sequence (5’-3’) 
 
VolA8HF  GCGCGCCATATGAAACAGGTTATTAAGCTC  
 
VolA8HR  GCGCGCGGATCCTTAATGATGATGATGATGA 
     TGATGATGATGATGCTTCAAGACAGAGTT 
 
551AR   GACAATTCCCCCTAATGCATGTCCCAGCATACGAA  
 
551AF   TTCGTATGCTGGGACATGCATTAGGGGGAATTGTC  
 
551TF   GTTCGTATGCTGGGACATACGTTAGGGGGAA 
            TTGTCGGC  
551TR   GCCGACAATTCCCCCTAACGTATGTCCCAGC 
            ATACGAAC 
 
PLAF   GCGCGCCATATGAAAAAGAAGCTAATTTAC  
 
PLAR   GCGCGCGGATCCTTACTGCTTGAGCAGGC 
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